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Optimization of Candida albicans Biofilms Inactivation by Benzophenoxazine Compounds  v 
for Photodynamic Therapy 
ABSTRACT 
The incidence of fungal infections has increased in the last decades, being Candida 
albicans the most common etiologic agent of fungal-related biofilm infections. In the last years, 
Candida strains have shown high levels of drug resistance, so the interest in new antifungal 
therapeutic options has increased. The antimicrobial photodynamic therapy (APDT) has been 
shown to be an emerging and promising approach to treat localized infections. The present 
dissertation aimed to optimize the antifungal photodynamic efficacy of two new 
benzophenoxazine-type fluorescent dyes against C. albicans biofilms by APDT, as well as to 
understand the different APDT outcomes achieved.  
The antifungal susceptibility of C. albicans planktonic cells to dyes N-[5-(3-
hydroxypropylamino)-10-methyl-9H-benzo[a]phenoxazin-9-ylidene]ethanaminium chloride (FSc) 
and N-(5-(11-hydroxyundecylamino)-10-methyl-9H-benzo[a]phenoxazin-9-ylidene)ethanaminium 
chloride (FSd) with concentrations in the range of 0-100 μM during 48 h was firstly determined. 
The potential photodynamic activity of dyes against C. albicans biofilms was then evaluated and 
optimized by incubation of biofilms with dyes in the range of 100-300 μM for 3 or 18 h followed 
by illumination at fluences of 12 or 36 J cm-2 through the use of a xenon arc lamp (600 ± 2 
nm). In order to understand the APDT outcomes achieved, dye uptake by the biofilm matrix and 
cells during dark incubation was also evaluated by spectrofluorimetric analysis (ex=590 nm; 
em=645 nm) and fluorescence microscopy.
On antifungal susceptibility assays, FSc dye showed no growth inhibition of C. albicans 
cells, while FSd produced a very poor growth inhibition when used at 50 and 100 μM. Regarding 
to APDT outcomes, only FSc dye showed to have photosensitizing activity against C. albicans 
biofilms. Using FSc at 300 μM for 18 h followed by illumination with 36 J cm-2 of fluence, a total 
photoinactivation of C. albicans biofilm cells was achieved. The notorious uptake of FSc over FSd 
dye by biofilms may explain its higher photodynamic effectiveness. 
In summary, data suggests that FSc-mediated APDT might be successfully used to treat 
C. albicans infections. 
Otimização da Inativação de Biofilmes de Candida albicans por Ação de Compostos do Tipo vii 
Benzofenoxazinas para Fototerapia Dinâmica 
RESUMO
A incidência de infeções fúngicas tem aumentado nas últimas décadas, sendo a espécie 
C. albicans o agente etiológico mais comum nas infeções causadas por biofilmes. Nos últimos 
anos, as estirpes do género Candida têm demonstrado elevados níveis de resistência aos 
agentes antifúngicos convencionais, impulsionando o interesse por novas terapias antifúngicas. A 
fototerapia dinâmica antimicrobiana é uma nova abordagem terapêutica que se tem 
demonstrado bastante promissora no tratamento de infeções localizadas. A presente dissertação 
teve como objetivo otimizar a inativação de biofilmes de C. albicans pela ação fotodinâmica 
antifúngica de dois novos corantes fluorescentes do tipo benzofenoxazina, assim como analisar 
as diferentes eficácias fotodinâmicas encontradas. 
Inicialmente determinou-se a suscetibilidade antifúngica aos corantes cloreto de N-(5-((3-
hidroxipropil)amino)-10-metil-9H-benzo[a]fenoxazina-9-ilidene)etanamínio (FSc) e cloreto de N-(5-
((11-hidroxiundecil)amino)-10-metil-9H-benzo[a]fenoxazina-9-ilidene)etanamínio (FSd) - utilizando 
concentrações de 0-100 μM durante 48 h em células planctónicas de C. albicans. A potencial 
atividade fotodinâmica dos corantes em biofilmes de C. albicans foi posteriormente avaliada e 
otimizada incubando os biofilmes de C. albicans com os corantes com concentrações de 100-
300 μM durante 3 ou 18 h, seguido de irradiação com uma lâmpada de arco de xénon (600 ± 2 
nm) com fluência de 12 ou 36 J cm-2. Com o intuito de entender as diferentes eficácias 
fotodinâmicas observadas, foi também avaliada a absorção dos corantes por espetrofluorimetria 
(ex=590 nm; em=645 nm) e microscopia de fluorescência. 
Os ensaios de suscetibilidade antifúngica revelaram que o corante FSc não apresenta 
efeito de inibição de crescimento, enquanto o corante FSd produz um pequeno efeito de inibição 
do crescimento quanto utlizado a 50 ou 100 μM. Relativamente à ação fotodinâmica 
antimicrobiana apenas o corante FSc demonstrou ter atividade fotossensibilizante nos biofilmes 
de C. albicans. Da incubação dos biofilmes com corante FSc a 300 μM durante 18 h, seguido de 
irradiação com 36 J cm-2 de fluência, obteve-se uma total inativação celular. A notória absorção 
do corante FSc em relação ao FSd pelos biofilmes poderá explicar a sua maior eficácia 
fotodinâmica. Em suma, os resultados indicam que o corante FSc poderá ser um potencial 
agente fotossensibilizante para a fototerapia dinâmica antifúngica de infeções provocadas por C. 
albicans. 
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PREAMBLE 
In the last decades, the incidence of superficial and systemic fungal infections has 
increased due to several factors, including the more frequent use of invasive procedures, 
prosthetic devices, immunosupressive medication and broad-spectrum antibiotics, as well as the 
increased incidence of neutropenia and HIV infections [1]. Yeasts from the genus Candida are 
responsible for 70-90% of the fungal infections cases, with Candida albicans representing about 
50% of all yeasts isolated in clinical samples [2, 3]. In fact, C. albicans is the most virulent 
Candida species and represents an important public health challenge with a high economic and 
medical relevance due to the increased costs of care, time of hospitalization and high morbidity 
and mortality rates, especially on immunocompromised patients [4]. In this context, conventional 
approaches of antifungal therapies can be time consuming, expensive and in the last years they 
have been largely associated with the emergence of resistant strains [5]. Thus, nowadays there is 
an increased necessity to discover alternative, more effective and localized antifungal therapeutic 
options to treat fungal infections [3].  
The photodynamic therapy (PDT), originally developed for the treatment of skin tumors, 
has been shown as an effective therapy to eliminate bacteria and fungi, even resistant strains, 
that cause localized infections of the skin and oral cavity [3, 6-8]. This approach combines a 
photoative molecule (a non-toxic dye), termed photosensitizer, with visible light and oxygen to 
produce cytotoxic oxygen species that are able to react with cellular components leading to cell 
dead [3, 9, 10]. Several studies have been shown that the use of the antimicrobial photodynamic 
therapy (APDT) as a therapeutic approach to treat localized infections is an emerging and 
promising field [3, 6-8]. Therefore, this dissertation aimed to contribute for the development of an 
APDT approach against candidosis. The principal aim of this work was to optimize the 
inactivation of C. albicans biofilms by APDT through the action of two new photosensitizers 
(benzophenoxazinium chlorides of different molecular size) that were synthetized by the 
Chemistry Department of University of Minho. A set of parameters that guarantees the 
inactivation of C. albicans biofilm cells by APDT was optimized in this work. These parameters 
include the photosensitizer concentration, the contact time with C. albicans biofilms that ensures 
dye uptake and the light dose that promotes the cytotoxic oxygen species production. 
xxiv 
 
Additionally, it was evaluated the dye uptake during the incubation conditions with the intent to 
verify if there is a correlation between the APDT outcomes achieved and the levels of dye uptake. 
The present dissertation is divided into four chapters. Chapter 1 is an introduction to the 
theme, where the C. albicans characteristics, pathogenicity, virulence factors and its 
mechanisms of drug resistance, as well as the principles of APDT are described. Additionally, this 
chapter also shows a short review of the main photosensitizers and light sources used, as well as 
the potential antifungal applications of APDT.  The second chapter includes the materials and 
methods used during all experimental work. On chapter 3 the results obtained and their 
discussion are presented. The last part (chapter 4) reveals the main conclusions and presents 
some suggestions for future works. 
Part of the results obtained in this dissertation were presented in the form of Poster in the 
“2nd Fungal Biofilms Meeting” Conference on May 20th and 21st of 2013 with the following 
reference: Lopes, Marisa, Alves, Carlos, Rama Raju, B., Gonçalves, S., Coutinho, P., Henriques, 
M., Belo, I. Antifungal Photodynamic Efficacy of Benzo[a]phenoxazinium Chlorides against 
Candida albicans Biofilms. 2nd Fungal Biofilm Conference, Glasgow, Scotland, 20-21 May, 2013. 
 
 
 
1. CHAPTER I
 INTRODUCTION 
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1.1. Candida albicans  
In nature there is a wide diversity of microorganisms, however only a small part is able to act 
like opportunistic pathogens and cause infections on human host. C. albicans is the most virulent 
among all the well-known clinically relevant Candida species and the species most predominant 
found on superficial fungal infections of the skin, oral cavity, esopaghus, intestinal and genital 
tract (candidosis), as well as in invasive blood stream infections (candidemia) [3].   
C. albicans is a commensal microorganism present in the normal flora of the human body 
that has an optimal growth at the body temperature (37ºC) [11]. Although they are commensals 
on the majority of healthy individuals, whenever the opportunity arises, i.e, whenever the body is 
immunocompromised or debilitated in some other way, C. albicans becomes a serious 
pathogenic and opportunist microorganism, causing serious fungal infections.  For these reasons, 
C. albicans is not only the main species related with oral mycoses but also the most common 
fungus affecting HIV infected patients and those with haematologic and oncologic malignancies 
during the immunosuppression period. In these patients, oropharyngeal candidosis episodes are 
the most cause of morbidity, which are of special concern, once oral candidosis can lead to 
esophageal candidosis and even more serious complications [3]. 
The cell wall of C. albicans is an essential component of its success as a pathogen [4]. It is 
required for growth, provides strength and protection against osmotic insult and establishes the 
contact between C. albicans cells and host tissues, through some associated cell surface 
macromolecules, leading to tissue invasion and colonization [12]. However, the pathogenicity of 
C. albicans may be attributed to several virulence factors including host defenses evasion, 
production of some tissue-damaging hydrolytic enzymes, as well as adherence and biofilm 
formation on host tissues and medical devices [4]. The biofilm formation ability is indeed the 
main virulence factor of C. albicans to the extent that it is the main responsible for its drug 
resistance against a wide range of conventional antifungal agents, including amphotericin B and 
fluconazole [4, 13]. Next will be reviewed each of these elements that contribute for C. albicans 
pathogenicity.  
 
4|INTRODUCTION 
1.1.1. The Role of C. albicans Cell Wall 
The fungal cell wall is a dynamic and highly organized organelle that determines both cell 
shape and its viability, as well as acts like a permeability barrier and determines the interaction 
between the microorganism and its environment [14, 15]. Because the fungal cell wall is a 
dynamic structure, it is continuously biosynthesized and extended during cell proliferation and 
growth phase. So, although the fungal cell wall has a protective function for cells, it is also 
responsible for the cell susceptibility to some antifungal agents that have the ability to disturb the 
processes by which the cell wall is synthesized [16].  
C. albicans cell wall is mostly composed by polysaccharides, representing around 80% of the 
cell wall dry weight. This structure consists in β-(1,3)-glucan covalently linked to β-(1,6)-glucan 
and chitin and is designed to work as a robust external skeleton, as well as a scaffold for the 
external glycoprotein layer that represents the other 20% of cell wall constituents. This layer 
includes not only lipids and various inorganic salts, but also many proteins that are involved in 
permeability control, interaction with hosts, recognition of other fungi and regulation of several 
processes [17, 18]. Besides the fungal cell wall being a crucial factor to host tissue evasion and 
colonization, it is also the first point of contact with innate immune system of the host and thus it 
also plays an important role in recognition and phagocytosis by host immune cells [15]. 
1.1.2. Virulence Factors of C. albicans 
It was believed, decades ago, that yeasts were passive participants of the pathogenesis 
process and the organic weakness and immunocompromised patients was the only mechanism 
that triggers the establishment of opportunistic infection. Nowadays, it is known that these 
microorganisms are active participants in the infection process, using mechanisms of host cells 
aggression termed virulence factors [4].   
C. albicans virulence factors include the ability to express specific host recognition and 
adhesion biomolecules, secretion of hydrolytic enzymes, morphologic transition between 
unicellular yeast cells and filamentous phase (hyphae and pseudo-hyphae) and the ability of 
biofilm formation on several surfaces [4, 11]. 
The primary factor that contributes to the C. albicans virulence is the host recognition and 
adhesion [4]. These two phenomena are conferred by specialized cell wall proteins termed 
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adhesins that bind specifically to peptides or sugar residues of other cells and/or increase the 
cell surface hydrophobicity, promoting the binding to abiotic surfaces through hydrophobic 
interactions [19]. The mechanisms of adhesion can be divided into two groups: lectin-like 
adhesion and sugar-insensitive adhesion [19]. The first one refers to lectin-like binding of 
adhesins to cell surface sugars residues, because these adhesins have a lectin-like carbohydrate 
binding domain. On the other hand, on sugar-insensitive adhesion, adhesins bind to peptides or 
raises the hydrophobicity of cell surface promoting the binding to certain abiotic surfaces [20]. 
One example of the later one in C. albicans is the Agglutinnin-like sequence (Als) proteins that 
specifically bind to peptides [21]. 
One of the most remarkable features of yeast adhesion is the ability to adapt the adhesion 
properties to new environments [19]. Several signaling pathways are involved in adhesins 
synthesis in response to stress, nutrient limitation or molecules produced by hosts. These include 
the Ras/cAMP/PKA, the Mitogen-activated Protein Kinase (MAPK) – dependent filamentous 
growth and the main glucose repression pathways [22]. Additionally, adhesins are submitted to 
stochastic expression patterns [23]. These cell wall proteins have a common structure of three 
domains: the C-terminal that links the adhesin to the cell wall, the N-terminal projected from the 
cell surface and the middle domain rich in threonine and serine-rich repeats [19].  Because of 
their similarity and repetitive occurrence, these repeats trigger recombination events and/or 
splippage during the DNA replication, offering an endless reservoir of adhesion properties to cells 
that gives them a great opportunity to quickly adapt to stressful environments [23].  
The production and release of hydrolytic enzymes, most of them resultant from extracellular 
secretion, are also a key factor on C. albicans virulence [4, 24]. These enzymes help on host 
adhesion, tissue invasion and destruction, as well as they are also thought to be responsible for 
changes on host immunity response [4]. The most discussed hydrolytic enzymes released during 
the pathogenic process are aspartic proteinases (Saps), but phospholipases and lipases are also 
hydrolytic enzymes that are involved in C. albicans virulence [24]. The proteolytic activity of Saps 
is attributed to a multigene SAP family of, at least, ten members that are differentially regulated 
and expressed on C. albicans infections, suggesting that different Saps have distinct roles during 
the infectious process [24]. These enzymes are responsible for the digestion or destruction of 
host cells membrane and degradation of host surface molecules, contributing to host tissue 
invasion [24]. Additionally, recent evidences have suggested that Saps are also involved in the 
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activation and maintenance of the inflammatory response in epithelial surfaces [25]. On the other 
hand, phospholipases are enzymes with the ability to hydrolyse ester bonds in 
glycerophospholipids [24]. Seven phospholipases have been identified [26] being the difference 
between their the mode of action and the target within the phospholipid molecule, which is the 
major component of cell membrane [24]. The functions of phospholipases on C. albicans 
virulence are not yet clear but they have showed to be involved in adhesion to epithelial cells and 
cell penetration [24] as well as in epithelium invasion [27] and may be in interaction with host 
signal transduction pathways [27]. Regarding to lipases, they have the ability to catalyse the 
hydrolysis of the ester bonds of phospholipids and mono- di- and triacylglycerols, but almost 
nothing is known about their role as C. albicans virulence factor. The potential roles of lipases 
that have been suggested include the digestion of lipids for nutrient acquisition, lyses of 
competitive microflora, adhesion to host tissues, as well as changes in immune cells [28, 29]. In 
addition, the production and release of haemolysins may also play a key role in C. albicans 
virulence [4]. C. albicans expresses haemolysins that allows the destruction of red blood cells 
and the acquisition of iron from host erythrocytes, an essential element for the development of 
microorganisms and a consequent establishment of infection [30]. 
The ability to go under a reversible morphologic transition between unicellular yeast cells and 
filamentous phase (hyphae and pseudo-hyphae) is another important virulence factor of C. 
albicans, with the extent that this ability provides cells with a flexibility of adaptation to hostile 
conditions imposed by the human body [4]. The filamentous phase raises resistance to 
phagocytosis and it has a cell wall containing three times more chitin that gives it more 
mechanical strength and makes epithelium penetration easier, allowing the invasion of more 
deep tissues [4, 31]. Although the parameters that triggers morphologic transition are not yet 
well understood, in vitro  studies show  that this behavior is influenced by temperature and pH: 
unicellular phase are stimulated  at 25ºC and acid pH, whereas filamentous phase is favored at 
37ºC with pH around neutrality [11]. 
The most important virulence factor of C. albicans is the capacity to form biofilm on several 
surfaces [4]. Recent evidence suggests that the majority of C. albicans infections are associated 
with biofilm formation [13]. In fact, Candida species, most notably C. albicans, are the main 
fungal species associated with biofilm formation causing superficial and deep-seated infections.  
This microorganism can colonize not only epithelial surfaces, but also numerous medical devices 
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(e.g. catheters and prosthetic devices, like voice prostheses, heart valves, denture surfaces and 
etc.) [3, 32].  
Biofilms are defined as highly well structured, coordinated and functionalized communities of 
microorganisms that are surface associated or attached to one another and embedded in a self-
produced protective extracellular matrix (ECM)  composed by diverse polymeric substances such 
as  cell wall glycoproteins and polysaccharides (e.g. β-glucan)  [4, 13, 33]. Fungal biofilms have 
defined key phases of development that were elucidated through the use of model systems. 
These key phases include the arrival to the substratum, adhesion, colonization, ECM production 
and deposition, biofilm maturation and cell dispersal [13]. Figure 1 shows the steps in C. 
albicans biofilm formation.  
 
Figure 1. Illustration of steps in Candida albicans biofilm formation. 1 and 2. Formation begins with 
adhesion of yeast cells to a surface by nonspecific interactions, such as hydrophobic and electrostatic 
forces, as well as specific adhesin-ligand bonds. 3. Attached cells proliferate to form microcolonies and 
start to deposit the ECM.4. The biofilm grow into a thick layer where ECM involves a complex network of 
yeast cells, hyphae and pseudohyphae. 5. Cells released or detached from the biofilm spread into the 
environment, dispersing infections and forming new biofilms. Adapted from [3]. 
The advantages to an organism of forming biofilms include the protection from the 
environment, resistance to chemical and physical stress, regulation of gene expression and 
metabolic cooperation [13]. Usually, the metabolic activity of biofilms is lower than planktonic 
cells due to existent nutritional restrictions, environmental physical stress and high cell 
population. These communities also show unique phenotype characteristics compared to their 
planktonic counterparts that confer them an increased resistance to antifungal agents [13, 34-
36]. In the clinical scenario, the problematic of drug resistance is very important since it enables 
biofilms to act as persistent sources of infection [13].  
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1.1.3. The Role of Biofilm in Antifungal Agents Resistance 
The increased resistance to antifungal agents is one of the defining characteristics of biofilms 
[13]. Nowadays, C. albicans biofilms show an increased resistance to a wide range of 
conventional antifungal agents, such as amphotericin B and fluconazole. This phenotype can be 
about twenty times more resistant to amphotericin B and one hundred times more resistant to 
fluconazole than the planktonically growth form [3, 37]. 
Antifungal resistance is both complex and multifaceted.  The resistant phenotype of 
planktonic cells is generally due to irreversible genetic changes, but biofilms are able to be 
resistant through their physical presence and cell density, which turns it into an almost inducible 
resistant phenotype independent from the genetic alterations [13]. Understanding the processes 
mentioned above enabled the science to unravel the mechanisms that are involved in drug 
resistance. Over the last few years, several factors that play a role in fungal biofilm resistance 
have been described, including the physiological state, cell density, extracellular matrix, efflux 
pump-mediated resistance, overexpression of drug targets and the presence of persister cells [4, 
13, 38]. 
 The general physiological state of cells in sessile populations are implicated on the 
susceptibility profiles of fungal biofilms [13]. Nutrient and oxygen limitation, particularly in the 
deeper cell layers of the biofilm, are responsible for slowing down the growth rate of these cells 
leading to cell’s surface alterations that consequently would result on a slower or inefficient drug 
uptake [34, 35, 39]. However, other factors like pH, temperature, changes in osmolarity, 
oxidative and ionic stress can also cause stress responses through conserved signaling pathways 
and perhaps alter their antifungal susceptibility, which suggests that more complex factors may 
be involved on drug resistance of biofilms [40, 41]. Some of the most tolerance responses 
triggered by these physiological stress factors is the activation of MAPK signal transduction 
network that is involved on biofilm development [22, 40], the activation of the Calcineurin via that 
plays among other things an important role on antifungal drug responses [42, 43] and finally the 
activation of the heat shock protein (HSP) Hsp90 that regulates complex cellular circuitry and 
potentiates the resistance to azoles and echinocandins in C. albicans, at least through the 
calcineurin via [44]. 
Cell density is also an important resistance factor of biofilm populations [13]. A previous 
investigation showed a phase-dependent increased antifungal resistance on the biofilm 
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development, supporting the belief that the physical density of cells within biofilms plays a role in 
drug resistance [45]. Within these highly dense communities there is a cooperation between cells 
through the quorum sensing systems, which enables them to promote communication and 
collective behaviors via the secretion of signaling molecules in a population-dependent manner 
[46]. This process allows communities to improve nutrient and niches accesses, as well as, 
collective defense against other competitive microorganisms and antifungal agents [3, 4]. 
However, some previous work have shown that both planktonic and biofilm resuspended cells 
shows similar resistant phenotype to the Clinical and Laboratory Standards Institute (CLSI) 
methodology, suggesting alternative mechanisms of resistance [47]. 
The ECM is an important feature of biofilms with the extent that this component provides to 
cells protection from host immunity and antifungal agents [48]. Its principal role in the antifungal 
resistance is the diffusion barrier effect that restricts drug diffusion throughout the biofilm 
structure, particularly to the deeper cell layers, and therefore, only the most superficial layers are 
exposed to lethal doses of antibiotics [35]. Recently, it was also been shown that the ECM 
composition of C. albicans biofilms have also a central role in drug resistance. In this respect, 
some recent results have shown that β-1,3 glucans are responsible to sequestering  azoles and 
thus conferring resistance on C. albicans biofilms [49]. Additionally, the regulation of ECM 
production may also be a key resistance factor [13]. It is thought that some glucoamylases and 
alcohol dehydrogenases may have positive roles on the matrix production and maturation phase 
of biofilms, respectively [50]. 
The fungistatic effect of the azoles against C. albicans induces a strong response of the 
biofilm population, allowing the development of some drug resistance mechanisms [13, 51]. The 
principal molecular mechanism of azole-resistance in C. albicans is the increased efflux of 
antifungal agents principally mediated by the Adenosine Triphosphate (ATP)-binding cassette and 
major facilitator superfamily (MFS) transporters [4, 45, 52]. The increased drug efflux by ATP-
binding cassette (ABC) transporters is due to the overexpression of the genes encoding drug 
efflux pumps CDR1 and CDR2, whereas the contribute of members of the MFS on azole-
resistance is mostly due to the overexpression of the MDR1 gene, a gene that encodes drug 
efflux pumps of MFS [45, 52, 53]. In fact, efflux pumps are an important determinant of fungal 
biofilm resistance. Their primary role may be the protection of cell to acute toxicity, but a clinical 
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exposure to azoles may triggers the levels of efflux pump expression and thus contributing for 
drug resistance [54]. 
Ergosterol alterations in biofilm cell membranes may also be the reason for C. albicans 
resistance to both azole and polyene-derived antifungal agents [45, 52]. Azoles actively bind to 
ERG11p enzyme (lanosterol 14-a-demethylase) encoded by ERG11 gene and block ergosterol 
biosynthesis, leading to a depletion of cell membrane ergosterol and the accumulation of toxic 
sterol pathways intermediates capable to inhibit cell growth [40, 55]. On the other hand, 
polyenes use the binding to cell membrane ergosterol to promote the formation of cell 
membrane pores and consequently cause the loss of intracellular substances, leading to cell 
dead [56]. Thus, amino acid substitutions in the enzyme ERG11p due to missense mutations on 
ERG11 gene or the overexpression of this enzyme may cause ergosterol alterations that elicit 
azole and polyenes resistance on C. albicans [55, 56]. It has been reported that mature C. 
albicans biofilms show an overexpression of the enzyme Erg11p, as well as a significant content 
of altered membrane ergosterol [3, 45].   
The presence of persistent cells (0.1-1% of biofilm population) is also one important 
mechanism of resistance in chronic infections that has gathered some recent attention in fungal 
biofilms [13, 57]. Persister cells are “dormant variants of regular cells that form stochastically in 
microbial populations and are highly tolerant to antibiotics” [58]. In particular for C. albicans 
biofilms, it has been described the presence of a small subpopulation of yeast cells that are 
highly resistant to amphotericin B, independently of efflux pumps upregulation or cell membrane 
composition [4, 13, 59]. It is thought that phenotypic adaptive changes arising from the 
prolonged and ineffectual antifungal treatment may be the responsible for the extraordinary 
survival ability of persister cells and thus for the antimicrobial drug failure [13]. However, the 
exactly mechanisms that enable these subpopulations to persist still remain unclear. 
The antifungal biofilm resistance seems to be a multifactorial and complex process, where 
antifungal agents with a single mechanism of action are likely to be poorly effective. Thus, other 
antifungal strategies with more effective mechanisms of action are needed [3, 34]. 
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1.2. ANTIMICROBIAL PHOTODYNAMIC THERAPY (APDT) 
The deadly effect of visible light when combined with chemical compounds was described 
for the first time by Oscar Rabb and his professor Herman Von Tappeiner in 1900. They found 
that visible light combined with acridine was able to inactivate cultures of Paramecium caudatum 
[14]. Shortly later, the essential role of the oxygen and light in the process was demonstrated by 
Von Tappeiner, who created  the term “Photodynamic” [6]. However, the potential of PDT against 
pathogens was not explored over several years for two principal reasons: some pathogens, 
especially gram-negative bacteria and protozoa, are poorly inactivated by PDT and the discovery 
of antibiotics, particularly the penicillin in 1928, raised the belief that every microbiological 
diseases would have been reduce to a level that nevermore would have impact on human health 
[14]. Such expectations were disappointed in the end of 50 decade with the emergence of 
resistant strains and then, the researches on the PDT approach were retaken [6, 14].  
In the 70s, it was discovered that porphyrins dyes localized selectively in tumors and so, 
PDT was initially developed as a cancer therapy. Since then, PDT has been clinically used for 
therapy of various diseases. So far, PDT is approved by FDA (Food and Drug Administration) for 
treatment of non-melanoma skin cancer (basocelullar carcinoma and Actinic Keratosis), choroidal 
neovascularization in age-related macular degeneration, as well as in treating lung and Barrett's 
esophagus cancer [10, 60, 61]. On the other hand, PDT investigations has included a wide range 
of applications, such as arterial restenosis prevention, therapy of another malignancies (prostate, 
neck, mesothelioma and brain) and autoimmune diseases, such as psoriasis [60, 61].  
Recently, antimicrobial PDT (APDT) has been proposed as an alternative approach to kill 
pathogens. APDT combines a non-toxic and light sensitive dye, termed photosensitizer, with 
oxygen and harmless visible light with appropriate wavelength, which matches with the 
absorption spectrum of photosensitizer [61-63]. 
Initially, this therapy requires a localized administration of the photosensitizer. Then, the 
photosensitizer taken up by cells or attached to them is excited with the visible light source, by 
photon absorption. On this state, the photosensitizer can undergo reaction with ambient oxygen 
and could originate cytotoxic oxygen species that may kill pathogens by oxidative modifications of 
the cellular constituents [14, 62, 64, 65].  
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1.2.1. Photophysical processes of PDT 
The photosensitizers used on this therapy are molecular structures characterized by 
conjugated double bounds containing a system of –electrons. In the photosensitizer ground 
(singlet) state these electrons are spin paired at the low energy orbitals. Upon application of the 
light with wavelength corresponding to the absorption peak of the photosensitizer, the electron in 
the highest occupied molecular orbital (HOMO) is excited to the lowest unoccupied molecular 
orbital (LUMO) and keeps its spin, leaving the photosensitizer in the excited singlet state, which is 
highly unstable and short lived (in the range of nanoseconds) [62, 66]. At this phase, the 
photosensitizer can rapidly return to the ground state, releasing the energy absorbed as 
fluorescence or suffering internal conversion, releasing heat. However, the most important event 
to the photodynamic therapy is the reversal of the excited electron’s spin, known as intersystem 
crossing, which leads the photosensitizers to the triplet state.  This state is less energetic than 
the previous state, but has a longer life time (in the range of microseconds) [64, 65]. 
In the triplet state, the photosensitizer may return to the ground state once again, by a newly 
change in the excited electron’s spin orientation followed by energy emission as 
phosphorescence or, alternatively, the photosensitizer may interact with  molecules in its 
immediate environment (essentially with molecular oxygen, O2) according two type of 
mechanisms: type I and type II reactions (Figure 2)[62, 64, 65].  
Figure 2. Schematic illustration of photodynamic therapy mechanism of action. Adapted from [62].
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Type I Reaction 
On the type I reaction, the triplet photosensitizer can transfer an electron and sometimes a 
simultaneous proton to O2, resulting on superoxide anion   2
 -   formation, which may undergo 
reaction and originate other reactive oxygen species (ROS), including the hydroxil radical ( OH) 
and hydrogen peroxide (H2O2) [62, 64].  
The ROS formed have a range of different reactivities.  OH, a strong electrophile that has 
the ability to chemically cause damage to a wide range of molecules, is undoubtedly the most 
reactive. H2O2 shows a less reactivity and  2
 -  is the least reactive [67]. However,  2
 -  may be 
converted to H2O2 and O2 by the superoxide dismutase enzyme. H2O2 is really reactive in the 
presence of ferrous irons and so, it may undergo reaction leading to  OH formation, through the 
well-known Fenton reaction (equation 1) [62, 66]. 
H2O2 + Fe 2+→ OH
- +  OH + Fe 3+          [Equation 1] 
More specifically, in the Fenton reaction occurs the homolytic fission of the oxygen-
oxygen bond in H2O2 molecule, resulting  in OH
-  and  OH formation,  through the oxidation of ion 
Fe 2+  to Fe 3+ [68].  
Type II Reaction 
The electronic structure of O2 in the ground state is a triplet. In other words, in the ground 
state, the O2 molecule has two outermost orbitals unpaired but spin parallel [64]. As the O2 ground 
state and the photosensitizer excited state is the same (triplet state), the collision between these 
two molecules can undergo energy transfer, transforming O2 in a more oxidant specie.  In a 
detailed way, type II reaction involves energy transfer to O2, resulting in a spin reversion of its 
outermost electron and its shifting into the orbital containing the other electron, leaving one 
orbital completely unoccupied.  As a result, the termed singlet oxygen (1O2) is formed and 
photosensitizer returns to the ground state [9, 62].  
Singlet oxygen is highly reactive, very short lived (around microsseconds), due to its very 
instable electronic configuration, and has a very limited diffusivity. Its high reactivity is 
responsible for a central role in the cellular damages during the photodynamic therapy and the 
 
 
14|INTRODUCTION 
 
limited diffusivity gives it a simultaneous localized effect (in a radius of approximately 20 nm) [60, 
62, 66].  
 Although both types of reactions can occur simultaneously in the presence of molecular 
oxygen, the second one occurs preferentially. Thus, singlet oxygen is not only more reactive than 
ROS, but also the main product of the photodynamic process, constituting the principal 
responsible for causing cellular damages [67].   
 
1.2.2. The Photobleaching Process 
 As a consequence of light exposure, the photochemical destruction of the photosensitizer 
can occur.  This process called photobleaching is generally denounced by the decrease of 
photosensitizer’s fluorescence intensity over time and can be minimized by decreasing 
illumination light intensity [66].  
 It was thought that the photobleaching process is due to a reaction between the 
photosensitizer molecule and singlet oxygen or ROS produced during illumination in a way that 
leads to a decrease of its efficacy for further photosensitization processes. However, in some 
cases the first product of photobleaching is a better photosensitizer than the initial molecule [66].  
   Photobleaching generally means a loss of reactivity but this process can have some 
beneficial effects towards selective treatments. In fact, it is thought that photobleaching may be 
responsible for the destruction of large amounts of photosensitizers on healthy tissues [69]. If 
this process occurs fast enough, healthy tissues may be spared from photodynamic cell 
damages, increasing injury site selectivity. However, there are still no clear evidences that the 
photobleaching can affect PDT treatments in this way [66, 70].  
 
1.2.3. Mechanism of Action of APDT 
The APDT Mechanism of action is quite different depending on the type of target microbial 
cells. The pathway where an initial increase of permeability of the cell wall is required, being an 
operative pathway for yeasts and also for gram-negative bacteria and protozoa in the cystic stage 
will be described [14].  
The process begins when the photosensitizer (positively charged) binds to negative charges 
of the cell wall, according to electrostatic forces. Then, this agent can modify the cell wall 
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permeability (in the dark or photo-induced), leading to a massive influx of the photosensitizer for 
the plasma membrane [14, 71]. At this point, a portion of the photosensitizer may cross the 
plasma membrane and take different subcellular localizations, especially when a prolonged 
incubation period is used. In the last few years, some authors have been described that certain 
photosensitizers can  cross the plasma membrane of eukaryotic cells and accumulate in 
mitochondria, lysosomes (vacuoles, in the case of fungi) or Golgi apparatus, as well as in 
endoplasmic reticulum [66].  
Upon illumination, the reactive cytotoxic species formed will oxidize the diverse cellular 
constituents within the microenvironment of the photosensitizer, affecting the cell functions and 
its metabolism in a manner that it can result in cellular apoptosis or necrosis [3, 14]. The 
mechanism of action that leads to fungi inactivation by APDT is illustrated in Figure 3.  
 
 
Figure 3. Illustrative scheme of essential steps involved on antifungal photodynamic therapy. Modified 
from [14].  
 As mentioned above, the cytotoxic effect of singlet oxygen is the most responsible for 
cellular inactivation. Singlet oxygen has a high probability to react with sulfur moieties and double 
Binding of the cationic photosensitizer with negative charges on the outer wall 
Dark or photo-induced alteration of the outer cell wall permeability  
Translocation of photosensitizers to the inner plasma membrane 
Photoactivation of photosensitizer and formation of reactive cytotoxic species 
Oxidative modification of specific targets in the photosensitizer microenvironment 
  
Impairment of cell functions and metabolism 
Inhibition of cell growth and cell death 
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bonds, having the ability to interact with aromatic components of macromolecules [62]. Thus, 
this product of type II reaction is a non-specific oxidizing agent that has multiple targets. It has 
the ability to oxidize aminoacids, inactivating some proteins and enzymes (e.g., catalase, 
superoxide dismutase, alcohol dehydrogenase, cytochrome coxidase, glyceraldehyde-3-phosphate 
dehydrogenase and hexokinase), as well as it is responsible for oxidation of nucleic acids and 
lipids peroxidation [9, 72]. In particular, lipids peroxidation can lead to the lyses of vacuoles, 
mitochondria and plasma membrane [3].  
Mitochondria are an important target of APDT. APDT induced mitochondrial damages 
have been related to the tendency of many photosensitizers to produce cell apoptosis involving 
the caspases pathway or the release of cytochrome c [66, 71]. However, plasma membrane 
represents the critical target of APDT. The damages caused on this organelle can lead to loss of 
barrier properties and inhibition of calcium and potassium transporter proteins, resulting in cell 
swelling, loss of cellular constituents, collapse of cell ionic balance, as well as deficiency of some 
essential substrates of anabolic and catabolic pathways [14, 73]. Additionally, the damage 
caused in the cell wall and plasma membrane may allow more photosensitizer to be translocated 
to endocytoplasmic districts and produce more reactive cytotoxic species upon illumination that 
will cause more oxidative modifications on a variety of cell targets [3, 66]. 
Although singlet oxygen can react with nucleic acids, several studies shown that the 
oxidative damages caused on plasmid and genomic DNA are not directly correlated with cell 
death [14, 74, 75]. In fact, DNA photo-induced oxidative modifications are little significant, since 
(i) the bacteria Deinococcus radiodurans, which has a highly efficient mechanism of DNA 
repairing, is  quickly  killed by APDT [14]; and wild strains of Escherichia coli  have similar 
sensitivity to inactivation by APDT than E. coli  strains with deficient DNA repairing mechanisms 
[76]. These observations are in agreement with the lack of mutagenic effects observed in 
photosensitization of microbial cells with several photosensitizers [14].  
1.2.4. Biofilms Eradication by APDT 
The clinical significance of biofilms is highlighted by recent estimates that over 65% of all 
hospital infections are originated by these microbial communities [41, 57]. A recent scanning 
electron microscopy studies [77, 78] have provided evidences that APDT has not only the ability 
to kill a wide of pathogens within the biofilm but also has a direct effect on biofilm extracellular 
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biomolecules. These authors described that the high reactivity of singlet oxygen exerts also effect 
on the matrix polysaccharides, leading to biofilm destruction [3]. This twofold activity of APDT in 
biofilm eradication may be very advantageous in clinical use because the structural rupture of 
biofilms may inhibit plasmid exchanges and transference of drug resistance factors, as well as 
may avoid new colonization and prevent recurrent infections [9].  However, there are only a few 
studies in this area and most of them were developed using biofilms of pathogenic bacteria. 
Given the high clinical relevance of fungi and fungal biofilms, there is a substantial need to 
provide a deep understanding about the APDT effect on these communities.  
 
1.2.5. Cellular Resistance Mechanisms to APDT 
 Since APDT products have no specific target and can cause damage to a variety of 
cellular constituents, it seems to be very unlikely that microbial cells can develop resistance to 
APDT [3]. 
 One mechanism that may provide cellular resistance to APDT is the inactivation of the 
oxygen reactive species H2O2, 
 OH and   
 - by antioxidants detoxifying enzymes, such as 
catalase, superoxide dismutase and peroxidase [62, 79]. For instance, the catalase enzyme can 
remove the hydrogen peroxide (H2O2) from the Fenton reaction on type I process, breaking down 
this molecule and forming water (H2O) and oxygen (O2) [80]. In addition, some antioxidants 
peptides, such as glutathione, may also quench some oxygen reactive species leading to the 
development of cellular resistance to APDT [62]. On the other hand, singlet oxygen cannot be 
broken down by antioxidant enzymes in any enzymatic reaction, by contrast it has sometimes the 
ability to inactivate them, which is the case of catalase and superoxide dismutase [81].  
 It was also thought that the general mechanisms of cell drug resistance, such as active 
efflux pumps, altered drug uptake and intracellular trafficking of the photosensitizer may 
contribute to the microbial resistance to APDT [3]. In the particular case of C. albicans, it has 
been shown that the two major efflux systems, ABC and MFS transporters, are responsible for 
the decrease of the killing effect of methylene blue (MB) – mediating APDT against this pathogen, 
which suggests that both type of transporters are involved in MB efflux. To overcome this 
problem, some authors proposed the combined use of efflux pumps inhibitors [3, 77]. However 
and according to Prates et al. [82], the phototoxic effect of MB is improved using an ABC 
transporter inhibitor, but is decreased when a MFS channel inhibitor is used, suggesting that 
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MFS channels are also an uptake mechanism of MB [82]. Nevertheless, some authors support 
that photosensitizers have not to be necessarily taken up by cells. The main important cellular 
targets of APDT are the cell wall and plasma membrane and so, photosensitizers that specific 
bind to these cell structures  will be potential photosensitizers for APDT of the target cell  [3]. 
 
On the other hand, some recent studies [79, 83] have revealed that the expression of HSP 
can be significantly increased after the photodynamic treatment. These proteins play an 
important role in refolding proteins and prevention of protein aggregation. So, it may constitute a 
mechanism whereby microbial cells could develop resistance to APDT.  For instance, in 2011 St 
Denis et al. [63] had demonstrated that APDT-mediated by Toluidine Blue (TBO) in E. coli and 
Enterococcus faecalis leads to the upregulation of the HSPs DNaK and GroEL and consequently 
its survival is increased in about 2 log and 4 log, respectively. However, the mechanism that 
leads to HSP expression is no yet completely understood and the combination of APDT with HSP 
inhibitors does not seem to potentiate the killing effect of APDT in both microorganisms [3].  
 
In summary, the studies and reports discussing the possible microbial resistance to APDT 
are scattered and sometimes are quite controversial.  Thus, a better knowledge in this field is 
needed and perhaps could provide new therapeutic approaches, such as the combination of 
APDT with other therapies [3].   
 
1.2.6. Applications of APDT 
The APDT potential have been investigated in a wide range of applications. Given that 
photosensitizers have a broad antimicrobial spectrum of action, their use as general disinfectants 
have been studied. This approach could be used to sterilize chirurgic material, blood products 
and also surfaces and floors of wards or other healthcare facilities. On this last application, 
photosensitizers could be applied as a wash liquid or spray and illuminated using ambient lights, 
that will induce the production of oxygen cytotoxic species and so, an antimicrobial effect that 
could lead to a decrease of the amount of microbial transmission in these places without induces 
drug resistance to the conventional drugs [9].  
On the other hand, applications like the sterilization of oral cavities and root canals, as 
well the treatment of localized infections (e.g. impetigo, candidosis and periodontitis) seems to be 
also a promising feature of APDT [6, 14, 60]. Besides these sites are readily accessible to topical 
delivery of photosensitizers and light, this therapy may also kill the resistant strains without arm 
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the surrounding tissues. Indeed, there is a possible set of optimal conditions that makes APDT 
suitable to treat localized infections [14]. The combination of an appropriated incubation time, 
low photosensitizer concentration and slight illumination parameters appears to allow a selective 
killing of pathogens, sparing human cells (e.g., keratinocytes and fibroblasts) from photo-induced 
cell damages [84-86]. Therefore, APDT provide a good antimicrobial alternative approach that 
may decrease the mortality rates of the microbial associated diseases [3]. 
 With the respect to photodynamic inactivation of C. albicans, superficial and localized 
infected tissues on the skin and mucosae, such as mucocutaneous candidosis, seems to be the 
main application of antifungal PDT [5]. Several classes of photosensitizers, mostly belonging to 
the phenothiazines and porphyrin classes have been used on APDT of Candida species growing 
on both planktonic cultures and biofilms (see section 1.3.2.) [3]. Many in vitro studies have been 
reported the use of APDT on killing Candida species and some in vivo studies have also been 
developed [7, 87-101]. 
 
1.3. PHOTOSENSITIZERS 
 In the last 30 years, the research on APDT field has significantly increased and thus, several 
forms of photosensitizers have been created. Photosensitizers are organic aromatic molecules 
constituted by large conjugated systems of double bonds that can be considered as a central 
cromophore combined with auxiliary side chains that are responsible for further electron 
delocalization of the photosensitizer [14, 62, 65]. Although APDT success is influenced by oxygen 
availability and illumination light dose, photosensitizer concentration, as well as its own properties 
are crucial parameters on the photodynamic inactivation process of pathogens  [3, 65, 67].   
 
1.3.1. Properties of Photosensitizers  
 The type and efficacy of cellular mechanisms of uptake of dye, as well as the pattern of 
its distribution into the cell are dependent on its chemical properties, such as the amphiphilic 
character, lipophilicity-hidrophilicity balance, degree of ionization or the presence of electric 
charged groups [5].  
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 In particular, the amphiphilic character and the presence of electric charged groups are 
very important factors on photosensitizer performance. While amphiphilic property avoid self-
aggregation of photosensitizer and provides a good penetration in the lipid layer of plasma 
membrane, the presence of electric charged groups provides electrostatic affinity that 
encourages the distribution of photosensitizer for various subcellular targets  [5, 66, 102].  
However, there are small details to consider depending on the target. Some photosensitizers that 
are efficient in killing gram-negative and gram-positive bacteria do not show the same therapeutic 
effect in fungi. For instance, a large number of positive charges are required to inactivate 
bacteria, but the same structural factor does not provide a good binding or uptake by fungi cells, 
especially if they are distributed homogeneously.  In this case, more lipophilic structures with less 
positive charges seem to be more appropriated [62].  
 Although there are small differences between suitable photosensitizers for fungi or 
bacteria, there is a consensus on the electronic character of photosensitizers. Cationic structures 
are more effective to kill both bacteria and fungi than anionic or neutral ones, due the 
electrostatic affinity provided between its positive charges and the negatively charged groups of 
cell wall and plasma membrane [14].  
 Recently, it was also established that there are essential photophysical and 
photochemical parameters that determine photosensitizing capability of a compound. These 
parameters are the absorption peak wavelenght (λmax), extinction coeficient (ε), triplet-state life 
time (τt), triplet-state quantum yield (Φt), triplet-state energy ( ΔEt)  and singlet oxygen quantum 
yield (ΦΔ), which are all specific of each photosensitizer and dependent on its molecular 
structure  [5, 65]. In short, a photosensitizer with optimal properties to APDT clinical use must 
have a wide range of properties. Table 1 describes the profile of an ideal photosensitizer for 
APDT use in the clinical field [5, 14, 64, 65, 70, 102].  
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Table 1. Profile of an ideal photosensitizer for APDT use in the clinical field [5, 14, 64, 65, 70, 102]. 
Characteristics Description 
Absorption peak 
Absorption in the long-wave region (>630 nm), preferably at a near red 
wavelength of the visible spectrum makes tissue penetration easier 
and avoids generalized photosensitization by sun light (400-600 nm).  
Exctintion coefficient 
High extinction coefficient of photosensitizer is required to increase the 
number of photons absorbed. Strong absorption of the light decreases 
the amount of photosensitizer required for a certain effect.  
Dark toxicity Low dark toxicity of photosensitizer is desired in APDT clinical use. 
Energy transfer  and quantum 
yields 
The energy transferred to O2 during the photophysical process of APDT 
must be sufficient to induce singlet oxygen formation. On the other 
hand, high quantum yield of the triplet-state, combined with high triplet 
life-time ( τT > 100 μs) and a high quantum yield of singlet oxygen is 
desired;  
Selectivity Selectivity to microbial cells is desired in the clinical field of ADT. 
Stability 
Photosensitizers must be stable enough to avoid degradation products. 
It also should not self- aggregate in the body because aggregates 
decrease the triplet-state and singlet oxygen quantum yields.  
Tolerability The damages caused on healthy tissues should be minimal. 
Pharmacokinetics 
Rapid removal from treated tissues and human body is required to 
avoid generalized photosensitization of the skin.   
Broad spectrum of action 
Photosensitizers should have a broad spectrum of action allowing the 
therapeutic of localized infections caused by a heterogeneous 
microflora of pathogens. 
Mutagenicity  
and resistant strains selection 
Photosensitizers should not induce genetic alterations. It should also 
minimize the risk of resistant strains selection. 
Availability 
Photosensitizers should be a simple formulation with easy chemical 
synthesis and its starting materials should be readily available. 
Moreover, it should be easily produced in large-scale to make it cost-
effective and widely available.  
Chemical structure 
Chemical structures of new photosensitizers should be deviations of 
other existent photosensitizers, allowing the improvement of its 
properties.   
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1.3.2. Most Common Photosensitizers in APDT 
The first generation of photosensitizers emerged in 1960 and comprised 
hematoprophyrins (Hp) and hematoporphyrin derivative (HpD), which is composed by 
monomeric and oligomeric porphyrins derived from human blood. Although its photosensitizing 
potential, both Hp and HpD were not suitable for APDT use [65]. Besides its exactly composition 
was unknown, its characteristics and distribution differed from preparation to preparation (which 
makes impossible to predict the therapeutic effect), the absorption spectrum (400-600 nm)  was 
less than that idealized for APDT use and the phototoxic effect were mainly promoted by 
unbounded molecules in the bulk aqueous solution leading to a mediocre killing effect [5, 65, 
102]. 
The second generation of photosensitizers was developed to fill the gaps of first 
generation. This new photosensitizers have longer wavelength absorption peaks (600-800 nm), 
that allows a deeper penetration of light in tissues (2-3 cm), reasonable stability, absent or low 
dark toxicity and good capability to induce singlet oxygen formation [65, 102]. There are 
numerous classes of photosensitizers belonging to this generation, which were firstly created for 
the antitumoral application of PDT. However, some of these agents have been also showing 
efficiency on APDT applications. Porphyrins, phthalocyanines and phenothiazines dyes are the 
most common photosensitizers used on APDT field (Figure 4) [5, 64, 103].  
Figure 4. Chemical structures of the main photosensitizers used on PDT. Modified from [14, 102, 104] 
Porphyrins 
Porphyrins of second generation are pure synthetic molecules that have a central 
structure composed by tetrapirrole conjugates, generally associated with various polar hydrophilic 
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substituents groups: hydroxy, carboxy, quaternary ammonium, sulfonic or pyridinium. These 
photosensitizers have absorption peaks in the 650 - 700 nm waveband and are 30-times more 
efficient than HpD.  [5, 102]. 
The polarity of these molecules is their critical factor. The more recent porphyrins 
derivatives are amphiphilic and water soluble molecules that are characterized by a greater 
uptake and, consequently, have a better activity against yeasts in comparison to  HpD or other 
porphyrins  derivatives [5]. In fact, a new cationic porphyrin photosensitizer - the meso-tetra (N-
methyl-4-pyridyl porphine tetra tosylate (TMP-1363) - was shown highly effective in APDT against 
yeast forms of C. albicans and C. glabrata [62] 
As microorganisms self-produce and accumulate porphyrins, it has also been adopted 
the endogeneous photosensitization of microbial cells through administration of a small non-dye 
aminoacid (5-aminolevulinic acid; ALA) [62, 105]. On this approach, exogenously supplied ALA 
enters into the microbial heme synthesis pathway, allowing an excessive accumulation of 
protoporphyrin IX (Pp IX). Upon illumination, Pp IX can act like an effective photosensitizer and 
produce photodamage at the mitochondria level (where it is synthetized), as well as on plasma 
membrane. Pp IX has its absorption peak at the 375-405 nm waveband, however it has other 
lowest peak at 630-633 nm region [5, 64, 106].  
Phthalocyanines 
Phthalocyanines have similar chemical structures to porphyrins and are characterized by 
the condensation of benzene rings with pyrrole moieties.  Chemical properties of phthalocyanines 
may be adjusted by modifying the central metal/semi-metal atom or the number and type of side 
chains. In fact, the central atom (Zn, AlIII, SiIV ou GeIV) plays an important role on the phototoxic 
activity. It may affect the triplet-state life time and quantum yield, as well as the introduction of 
polar substituents on side chains, which will influence the polarity balance and, consequently, the 
cell uptake and its distribution into microbial cells [5].  
Phthalocyanines have great singlet oxygen quantum yield and high extinction coefficient 
in the far red (680-720 nm). Despite the lack of knowledge about the phthalocyanines cell 
targets, they have showed to be effective against C. albicans.  One recent photosensitizer of this 
family, BAM-SiPC (also known as malachite green), has been shown a great activity against some 
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pathogens by APDT, including C. albicans [62]. Moreover, other study conducted by Lam et al. 
[94] showed that phthalocyanine PC4-mediated APDT can induce apoptosis of C. albicans cells.  
Phenothiazines 
Phenothiazines have a very dissimilar chemical structure in comparison to all dyes 
mentioned above. These dyes have simple planar and tricyclic skeleton combined with polar 
substituents (side chains), having its absorption peak in the 600-900 nm waveband [5, 103]. The 
most frequent used phenothiazines derivatives are MB and TBO, two efficient producers of singlet 
oxygen that have its absorption peak at 656 nm and 625 nm, respectively [5, 64].  
In yeasts, phenothiazines tend to accumulate on plasma membrane and damage it after 
light exposure. Both MB and TBO have been shown efficient photosensitizers to C. albicans 
photoinactivation by APDT [5]. In particular, MB and its analogues show killing rates 18-200 
times bigger  than those determined for keratinocytes, suggesting that MB-APDT of fungal 
infections of the skin can be highly effective and selective [5].  
1.3.3. Benzo[a]phenoxazines 
Phenoxazines have a similar chemical structure of phenothiazines with the difference 
that has an oxygen atom replacing the sulfur atom (Figure 5A). Benzophenoxazines are the result 
of addition of benzene rings to phenoxazines and thus, they may have linear, 
(benzo[b]phenoxazine) or angular structures (benzo[a]phenoxazine and benzo[c]phenoxazine), 
depending on orientation of benzene ring fusion. Despite there are three types of structures, only 
benzo[a]phenoxazines have been molecules of interest and widely explored in contemporary 
science [104].  The presence of substituents groups in some orientations of these structures may 
give it the ability to freely donate and/or accept electron density, granting them the capacity to 
emit fluorescence and so, some benzo[a]phenoxazines have been widely used as biomolecular 
probes of DNA and RNA in fluorescence studies [104]. 
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Figure 5. (A) Chemical structure of phenoxazines and benzophenoxazines; (B) Structures of the three 
best known benzo[a]phenoxazines. Adapted from [104].  
The first benzo[a]phenoxazine to be discovered was Meldola’s Blue, however Nile Blue 
and Nile Red are by far the more used (Figure 5B) [104]. As Meldola’s Blue is poorly water-
soluble and Nile Red is a neutral benzo[a]phenoxazine (and so, also poorly water-soluble), the 
positively charged benzo[a]phenoxazine Nile Blue is the only one of interest for APDT [103, 104]. 
Nile Blue, which has its absorption peak localized at 635 nm, has a positively charged and 
oxidized phenoxazine system, i.e, it is a benzo[a]phenoxazinium dye and has a 9-diethylamino 
substituent to donate electron density across the ring and an iminium substituent to act as 
acceptor [104].   
As a result of research on PDT field, there have been created some Nile Blue derivatives 
that may have its absorption peak in the 600-700 waveband [104].  In the clinical field, 
commercial Nile Blue and some selected derivatives has been showed a high biological selectivity 
to tumoral tissues accompanied by a quickly pharmacokinetic elimination (24 hours post 
administration) [104, 107]. Accordingly to Foley et al. [103], some Nile Blue chalcogens 
analogues can also have a great photo-induced activity against yeasts and bacteria, such as  C. 
albicans, E. coli and E. faecalis [64].  
Certainly, the possibility to synthetize new benzo[a]phenoxazinium dyes derived from Nile 
Blue with better pharmacologic and physic-chemical properties may be a promising approach to 
create new APDT photosensitizers. Benzo[a]phenoxazinium dyes may have some characteristics 
that make them good photosensitizers for APDT application.  They are: broad-spectrum of action; 
efficient absorbers of 600-700 nm light; good cell binding and cell uptake; great photo-induced 
activity against pathogens; and high singlet oxygen quantum yield [103].  
A B 
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1.3.4. Formulation of New Concepts 
The list of photosensitizers for APDT use has still expanding, especially the ones focused 
to inactivate pathogenic fungi such as C. albicans. Curcumin, chlorin e6, bacteriochlorin, boron 
difluoride (BF2) or Rose Bengal (RB) are some examples of new photosensitizers that have been 
shown effective in killing yeasts by APDT, including C. albicans [62].   
Alternatively, the combination of photosensitizers with compounds that create pores 
within the fungal membrane may increase the cellular uptake and thus, may be a potent strategy 
for treatment of fungal infections. Saponins and polyenes, such as amphotericin B and nystatin, 
are compounds with pore-forming properties that may be used in conjunction with 
photosensitizers on this strategy [62]. For instance, Coleman et al. [108] reported that  the 
pretreatment of C. albicans cells with a saponin significantly increased the influx of Rose Bengal 
and Chlorin e6, as well increased 2-5 log the killing  effect of this photosensitizer upon 
illumination with low-intensity light at the correct wavelength. 
Furthermore, the emerging of a third generation photosensitizers has been also studied. 
This new generation has the principal aim to overcome the problem of aggregation of 
photosensitizer in aqueous solutions, as well as improve photosensitizer delivery and inactivation 
kinetics [62, 109, 110]. In this strategy, photosensitizer delivery is achieved through carriers like 
liposomes, micelles and nanoparticles that may be also combined with specific antibodies for the 
target [102, 111]. Among these carriers, liposomes are the most commonly used carrier and 
have been proved to enhance the killing effect of many photosensitizers by APDT. They increase 
photosensitizer’s solubility and stability, as well as facilitate the penetration into cell by means of 
fusion processes or disturbing the cell wall [112].  
 
1.4. LIGHT SOURCES AND DELIVERY 
1.4.1. The concept of Light Fluence and Source Irradiance  
 By definition, APDT requires a light source with a wavelength that matches with 
absorption spectrum of the photosensitizer to supply the requested energy for inducing singlet 
oxygen production or promoting redox reactions. Therefore, the efficiency of APDT process is 
directly dependent on light exposure [9].   
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 In light based medicine and dentistry, radiant exposure is defined as fluence and is a 
measurement of energy (Joule) over area (usually cm2) of the light device spot size. Other 
relevant concept is the light source irradiance, which is a measurement of source power (Watt) 
per area (usually cm2) of light device spot size. Typically, irradiances for light sources in 
antifungal PDT are in the range of 10-100 mW cm-2, with light fluence comprised between 10 
and 200 J cm-2 [3].  The crucial point in this light dosimetry is to avoid  thermal effects of light 
when power outputs above 100 mW cm-2 are needed [62].  
 Indeed, there is no need to use high light doses. The anti-tumoral PDT research 
demonstrated that at low irradiances, oxygen consuming is lowest and thus, exposure period of 
tissues to singlet oxygen are longest, resulting in a high therapeutic response. Other researches 
in the antifungal PDT have  also shown that C. albicans cells can be significantly killed at 
relatively low light intensities [62]. 
 
1.4.2. Light Penetration 
  The light fluences applied to the biological sites decreases exponentially with the 
penetration into the tissues by the combination of some dispersive and absorption effects. The 
proportion between these two processes is dependent on tissue type and light wavelength [66].  
 As is known, skin is irregular, inhomogeneous and has microscopic structures like 
follicles, cell organelles, macromolecules and natural cromophores, so, a portion of received 
photons may be reflected, dispersed or absorbed until reach the target [66]. It was of general 
agreement that tissue penetration of light increases with the increase of light wavelength in the 
visible spectrum (400-700 nm) [6, 66]. Thus, light sources with wavelength in the far red can do 
a good penetration into the skin, as well as photosensitizers with absorption peak in this range 
are the most suitable to kill dermatophytes that colonizes stratum corneum and hair follicles [5]. 
 
1.4.3. Most Common Light Sources in PDT 
 In the PDT field it has been used a wide range of lamps and lasers as light sources. 
While lasers provides highly coherent monochromatic light, decreasing the required time to reach 
a given light dose, lamps has a wide range of wavelengths a so, they can be used with numerous 
photosensitizers.  At the level of clinical treatment of localized infections on the skin or oral cavity, 
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both lasers and lamps provide direct illumination of the injury site. However, lasers may be used 
to illuminate some site of more difficult access like esophagus, by means of optical fibers with 
diameters less than 500 µm that can be fed through existent channels in bronchoscopes and 
endoscopes. Table 2 shows the most widely used lamps and lasers on PDT applications [69, 
113]. 
Table 2. Lamps and lasers more frequent used on PDT applications. Adapted from [113] 
Light Source 
Irradiance 
(mW cm- 2) 
Wavelength (nm) bandwidth (nm) 
La
se
rs
 
Argon laser 500-1000 488-514,5 
Monochorom 
(5-10 nm) 
Metal vapour laser Up to 10000 
UV ou visível 
(depending on metal) 
Solid state Up to 10000 1064; 532; 355; 266 
Semiconductor 
diode laser 
Up to 700 600-950 Monochorom 
La
m
p
s 
Tungsten filament Up to 250 400-1100 
10-100 (depending 
on filters used) 
Xenon arc Up to 300 300-1200 
Metal halide Up to 250 
Depending on the 
metal, lines between 
250-730 
sodium (phosphor 
coated) 
Up to 100 590-670 
10-80 (depending on 
filters used) 
Fluorescent Up to 10 400-450 ≈ 30 
Light-emitting 
Diode (LED) 
Up to 150 400-1000 (5-10 nm) 
2. CHAPTER II
MATERIALS AND METHODS 
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2.1. Benzophenoxazines Origin 
The benzophenoxazines dyes used in this work were synthetized in the Department of 
Chemistry of University of Minho and were gently provide by Professor Maria Sameiro Torres 
Gonçalves.  
The benzo[a]phenoxazinium chlorides termed N-[5-(3-hydroxypropylamino)-10-methyl-9H-
benzo[a]phenoxazin-9-ylidene]ethanaminium chloride - FSc [114] and N-(5-(11-
hydroxyundecylamino)-10-methyl-9H-benzo[a]phenoxazin-9-ylidene)ethanaminium chloride - FSd 
[115] were the dyes selected for this work. As shown in Figure 6 the molecular structures of 
these dyes are similar, but FSd dye has a longer side chain. Table 3 also shows the main 
photophysical properties of these dyes. 
Figure 6. Chemical structure of FSc (A) and FSd (B) dyes. 
Table 3. Photophysical properties of pertinent dyes. 
Dye 
Photophysical Properties 
 in Ethanol 
Photophysical Properties 
 in Water (pH 7,5) 
máx (nm)1 ex(nm)2 em(nm)3 ΦF
4 máx(nm) 1 ex(nm) 2 em(nm)3 ΦF4 
FSc 625 590 646 0.41 620 580 651 0.31 
FSd 616 590 654 0.29 
1 Wavelength of maximum absorption; 2 Excitation Wavelength; 3 Emission wavelength; 4 Absolute 
fluorescence quantum yield.  
2.2. Benzophenoxazines Stock Solutions 
Stock solutions of each dye were prepared by solubilizing benzophenoxazines powder in 
Dimethyl Sulfoxide (DMSO) to a final concentration of 10 mM. Then, the solutions were 
transferred to 1.5 ml sterile amber microtubes (VWR Internacional, LLC. USA) to avoid ambient 
light and were stored at 4 °C. 
A B 
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Immediately before each experiment, aliquots of the dyes were diluted in sterile 
Phosphate Buffered Saline solution (PBS; pH 7.5; 0.1 M), which was previously prepared, to 
obtain working solutions with 1mM concentration. Then, these solutions were diluted again in 
PBS in order to obtain the required working concentrations.  All the solutions were prepared on 
1.5 ml sterile brown microtubes as described above. 
PBS solution was prepared in sterilized water by adding 8 g l-1 of sodium chloride (NaCl), 
0.2 g l-1 of potassium chloride (KCl), 0.3 g l-1 of potassium dihydrogen phosphate (KH2PO4) and 
1.15 g l-1 of disodium phosphate (Na2HPO4). The pH was adjusted to 7.0 and the solution was 
autoclaved at 121 ˚C for 15 minutes and reserved at room temperature. 
2.3. Organism, Culture Media and Growth Conditions 
 The microorganism used in this study was Candida albicans ATCC 90028, a reference 
yeast strain from American Type Culture Collection. This strain was preserved at -80ºC in a 
storage solution of Sabouraud Dextrose Broth (SDB; Liofilchem®, Roseto degli Abruzzi, Italy) 
supplemented with 10% of glycerol.  
SDB and Sabouraud Dextrose Agar plates (SDA; Liofilchem®, Roseto degli Abruzzi, Italy) 
were prepared at 30 g l-1 concentration of SDB in distilled water and SDA by supplementation of 
SDB with 20 g l-1 of agar (Liofilchem®). Then, both media were sterilized in a steam autoclave at 
121°C for 15 minutes and were stored at room temperature. RPMI-1640 medium were prepared 
by dissolving 10.4 g l-1 of this powder in distilled water and adding 34.53 g l-1 of MOPS (Sigma 
Aldrich, Portugal). Finally the pH was adjusted to 7 and the medium was sterilized by filtration 
through a 0.22 μm cellulose filter. 
Previously to each experiment, yeast cells were sub-cultured on SDA for 48 h at 37ºC. 
Then, one loopful of single-cell colonies (3-5 colonies) was inoculated in 30 ml of SDB and 
incubated for 18 h, at 37ºC, under constant agitation of 120 rpm. After this step, cells were 
harvested by centrifugation at 3000 x g for 10 min at 4°C and washed twice with 15 ml of PBS. 
The pellets were then suspended in 10 ml of sterile RPMI-1640 (Sigma Aldrich, St Louis, USA), 
for antifungal susceptibility testing, and in 10 ml of SDB for the remaining experiments. The 
cellular density was adjusted, depending on the experiment, using an improved Neubauer 
haemocytometer (Marienfild, Land-Könicshofen, Germany).  
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2.4. Antifungal Susceptibility Testing 
The antifungal susceptibility testing was performed under the orientation of M27-A2 
document from NCCLS - National Committee for clinical Laboratory Standards - [116] with some 
modifications.  
Different dyes concentration at twofold final concentration (20, 25, 30, 50, 100 and 200 
µM) were firstly prepared in PBS, previously to each experiment. Then, standardized cell 
suspensions (100 µl of containing 2x107 cells ml-1 or 2x108 cells ml-1 in RPMI) were combined 
with 100 µl of each dye at concentrations described above in  respective wells of Biolite 96-well 
multidish plates (Thermo Fischer Scientific, Waltham, USA).  
The microplates were incubated in the dark at 37°C during 48 h and the number of 
cultivable cells was then determined by counting colony forming units (CFUs). Briefly, the cell 
suspensions of each 3 wells per condition were collected and vortexed during 1 min. Then, serial 
dilutions on PBS were done and plated onto SDA. After 24 h of incubation at 37ºC, the number 
of colonies formed was counted and the total CFUs per unit of volume were determined. These 
experiments were performed three times with at least each condition evaluated in triplicate. 
Negative, dyes and yeast controls were also included. 
2.5. Biofilm Formation 
Standardized cell suspensions (200 µl of containing 1x107 cells ml-1 in SDB) were placed 
into selected wells of 96-wells polystyrene microtiter plates (Orange Scientific, Braine-l’Alleud, 
Belgium) and incubated at 37°C under agitation at 120 rpm. At 24 h, 100 µl of SDB medium 
was removed and the same volume of fresh SDB was added. The preparations were then 
incubated for a further 24 h. After biofilm formation the medium was aspirated and non-adherent 
cells removed by washing biofilms once in 200 μl of PBS.  
2.6. Quantification of Cultivable Biofilm Cells 
In order to determine the number of biofilm cultivable cells on dark toxicity and 
photodynamic inactivation assays, the biofilms were firstly resuspended in 200 μl of PBS by 
scrapping the adhered biomass from the wells using a mechanic technique and repeated 
pipetting. Then, these 200 μl were collected to a sterile microtube and the same method was 
done with 100 μl of PBS to guarantee that each biofilm cell was totally resuspended.  The 
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resulting resuspended biofilms of each 3 wells per condition (on the case of dark toxicity assay) 
and 2 wells per condition (on the case of photodynamic inactivation assays) were collected and 
vigorously vortexed during 1 min to disrupt the biofilm matrix. Then, serial decimal dilutions in 
PBS were done and plated onto SDA. Agar plates were incubated at 37 ºC for 24 h and the total 
CFUs per unit area (Log CFU cm-2) of microtiter plate well was enumerated. 
2.7. Antifungal Photodynamic Therapy 
2.7.1. Dark Toxicity  
To verify the absence of antifungal activity of each dye on C. albicans biofilms, 
standardized solutions of FSc or FSd dye with 100, 200 and 300 µM concentration, previously 
prepared, were added to wells after biofilm formation and the microtiter plates were then 
incubated in the dark at 37ºC during 3 h or 18 h with constant agitation at 120 rpm.  
Afterwards, dye solutions were aspired and the biofilms were washed twice in 200 μl of 
PBS to remove loosely attached cells and excess of dye.  Then, 200 μl of PBS were added again 
to wells and the number of cultivable biofilm cells was determined by counting colony forming 
units (CFUs) as described on section 2.6. These experiments were performed three times with 
each condition evaluated in triplicate. Negative, dyes and yeast controls were also included.  
2.7.2. Photodynamic Inactivation 
In this experiment, the biofilms were formed and specific concentrations of FSc and FSd 
(100, 200 and 300 µM) were added (as described above) on selected wells of the microtiter 
plate, leaving an interval of three wells between each well used, to avoid side light exposure 
during biofilms illumination.   
After dark incubation during 3 h or 18 h in the same conditions as described on section 
2.7.1, dyes solutions were aspired and biofilms were washed twice in 200 μl of PBS to remove 
loosely attached cells and excess of dye. Then, 200 μl of PBS were added again to wells and 
each biofilm was aseptically (assured with a Bunsen burner) illuminated at an average irradiance 
of 10 mW cm-2 with a xenon arc lamp (OSRAM HBO 200W) equipped with a bandpass filter 
centered on 600 ±2 nm (ThorLabs, New Jersey, USA). Biofilms were illuminated during 20 or 60 
minutes, which corresponds to a light fluence of 12 J cm-2 and 36 J cm-2, respectively.  Exact 
power was measured at the end of every experiment with an integrating sphere photodiode 
power sensor (model S144C; ThorLabs) using the PM100D Utility software (Thorlabs). 
 MATERIALS AND METHODS|35 
 
The number of cultivable biofilm cells was then determined by CFUs after biofilm cells 
resuspension, as described on section 2.6. Negative, dyes and yeast controls, even as light 
controls (illumination of biofilm with PBS only; light fluence=12 J cm-2 or 36 J cm-2) and dark 
controls (biofilm with dyes in the absence of light; light fluence=0 J cm-2) were also included. 
Experiments were repeated three times with each condition evaluated in duplicate. 
2.7.3. Absorption Spectra of Biofilms  
 The absorption spectrum of each biofilm illuminated was also determined previously and 
after the biofilm illumination. This step was intended to observe possible dyes alterations or 
aggregations during light exposure. The absorption spectrum was measured using an optical fiber 
and the ThorLabs SPLICCO software (ThorLabs, New Jersey, USA). The selected absorption 
spectrum of each condition tested is on appendix A.  
2.8. Dye Uptake 
 Dye uptake assays were realized to verify if photodynamic inactivation was correlated 
with dye uptake, even as to observe if that effect was influenced in a concentration-dependent 
manner.  
After biofilm formation, biofilms were incubated in the dark with both dyes at the 
concentration of 100 and 300 μM during 3 h or 18 h at the same conditions as described on 
section 2.7.1. After dark incubation, biofilms were washed twice in 200 μl of PBS to remove 
excess of dye and loosely adhered cells. Then, the same volume of PBS was added and the 
biofilms were resuspended as described above (section 2.6). The resulting resuspended biofilms 
of each 3 wells per condition were collected, centrifuged at 6654 x g for 5 min at 4°C and the 
supernatants were then collected for fluorescence analysis, to achieve dye retained in the biofilm 
matrix during dark incubation. These pellets were resuspended in 900 μl of PBS and cells were 
lysed by sonication (3 cycles of 60 seconds with 30 seconds off between each cycle, at 20 kHz 
and 35% of power output) through a VCX750 ultrasonic processor (Cole-Parmer, USA). The 
resulting lysates were centrifuged and the supernatant was removed for fluorescence analysis to 
achieve dye taken up by cells during dark incubation. It is important to emphasize that sonication 
parameters were previously optimized in order to promote the complete lysis of all biofilm cells.  
For fluorescence analysis, 200 μl of each supernatant solution were placed in triplicate 
on selected wells of a black 96-wells pureGrade microtiter plate (VWR, Portugal). Fluorescence 
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was determined through a microtiter plate reader (Bio-Tek® Synergy HT, Izasa, Portugal) with 
excitation wavelength set to 590 nm and the emission wavelength set to 645 nm. The sensibility 
of device was set to 80 and the agitation intensity was defined for 1 with the duration of 3 
seconds. 
Results were expressed as concentration of dye on supernatant (μM). The concentration 
of dye was determined through previously prepared standard curves of fluorescence intensity 
versus concentration of dyes in PBS (Appendix B). Experiments were repeated three times with 
each condition evaluated in triplicate. Control wells containing biofilm with only PBS were also 
performed and treated as the remaining samples to determine whether PBS and the remaining 
biomass, even as the material plate could interfere with fluorescence intensity of the samples. 
2.9. Fluorescence Microscopy  
 In this experiment, fluorescence microscopy analysis was performed in planktonic cells 
and biofilm resuspended cells, in order to observe the differences of dye uptake by cells on each 
approach.  
2.9.1. Fluorescence Microscopy of Planktonic Cells 
For fluorescence microscopy of planktonic cells, cells were inoculated in SDB for 18 h at 
37ºC under agitation at 120 rpm. Then, cells were harvested by centrifugation (3000 x g for 10 
min at 4ºC) and washed twice in 15 ml of PBS. After cells resuspension in 10 ml of PBS, the 
cells density was adjusted to 1x107 cells ml-1 and aliquots of 200 μl of this cell suspension was 
added to a 15 ml Falcon-tube (Orange Scientific, Belgium). Afterwards, these cells were 
harvested again by centrifugation at 1700 x g for 5 min at 4ºC, resuspended in 200 μl of each 
dye solution at a concentration of 300 μM and incubated in the dark for 3 h or 18 h at the same 
conditions described on section 2.7.1. After this step, cells were harvested by centrifugation at 
1700 x g for 5 min at room temperature and washed twice in 200 μl PBS. After the last wash, 
the resulting pellets were resuspended on 20 μl of PBS, transferred to microscope slides and 
examined in a BX51 Olympus Fluorescence Microscope through a TRITC filter, using the same 
exposure time. The obtained images are result of one single experiment with a single evaluation 
of each condition. 
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2.9.2. Fluorescence Microscopy of Biofilm Resuspended Cells 
For fluorescence microscopy analysis of biofilm resuspended cells, several biofilms were 
formed and incubated in the dark with both dyes at the 300 μM concentration for 3 and 18 h at 
the same conditions described on section 2.7.1. After the dark incubation step, biofilms were 
washed twice in 200 μl of PBS and resuspended in the same volume of PBS through using a 
mechanic technique and repeated pipetting. Then, cells were harvested by centrifugation at 1700 
x g for 5 min at room temperature and washed again twice in 200 μl of PBS.  Then, samples 
were analyzed as previously described for the planktonic cells. The obtained images are result of 
one single experiment with a single evaluation of each condition.  
2.10. Statistical Analysis 
Statistical analysis was performed using the statistical program GraphPad Prism 5. All 
data were compared using two-way analysis of variance (ANOVA) by applying the Bonferroni post-
test. Tests were performed with a confidence level of 95%. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
3. CHAPTER III 
RESULTS AND DISCUSSION 
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3.1. Antifungal Susceptibility Testing 
The benzo[a]phenoxazinium chloride FSc was previously applied in planktonic C. 
albicans cells, showing potential application on APDT of this yeast species [117]. Therefore, it 
was important to assess the effect of this dye in C. albicans biofilms. Additionally, FSc was also 
compared with FSd dye, a new benzophenoxazinium chloride that is very similar to FSc but has a 
longer side chain.  
Dyes were firstly compared in planktonic cells. The antifungal susceptibility testing was 
performed with two high cellular concentrations to mimic biofilm condition and to observe if the 
cellular concentration could influence the C. albicans susceptibility to these dyes. The viable cells 
were quantified by counting colony forming units (CFU). The susceptibility of both C. albicans 
cells suspensions to the benzo[a]phenoxazinium chlorides FSc and FSd is illustrated in Figure 7. 
Figure 7. Susceptibility of C. albicans ATCC 90028 planktonic cells exposed for 48 h to FSc (A) and FSd 
(B) dye in RPMI. Error bars represent standard deviation. *Statistically different from the respective 
control, 0 μM (P <0.05). 
As shown in Figure 7A, for both cell concentrations used, there were no significant 
differences in the number of viable cells (P >0.05) after treatment with different FSc 
concentrations and they were similar to the negative control (absence of the agent). Likewise, 
Figure 7B shows that the presence of FSd dye in the concentrations of 10 to 25 μM in both cell 
concentrations and the 50 μM concentration in the highest suspension did not cause significant 
changes in the number of viable cells, when compared to the respective negative control.  
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 On the other hand, for the cell suspension of 1x107 cells ml-1 it was found significant (P 
<0.05) growth inhibition of 0.93 log and 1.13 log when FSd concentration was 50 and 100 μM, 
respectively. Moreover, for the cell suspensions of 1x108 cells ml-1 there was also a small growth 
inhibition, but statistically significant (P <0.05), of 0.81 log when the concentration of FSd was 
100 μM.  
 
In summary, the results showed on Figure 7 turns clear evident that only FSd dye can 
have antifungal activity against C. albicans suspensions in these conditions, although the growth 
inhibition produced by this dye was very poor. The difference on antifungal activity between these 
dyes may be related to their structural differences, indicating that side-chain modifications can 
have significant impact on their growth inhibition effect [118]. The previous work that evaluated 
the potential of FSc dye as a photosensitizer on C. albicans planktonic cells [117] also 
determined the susceptibility of these cells to FSc dye after 48 h. In opposition to the results 
presented on Figure 7, the previous susceptibility testing assays showed 90 and 100% of  growth 
inhibition when FSc dye was used on cell suspensions of 2x106 cells ml-1 at 50 and 100 μM, 
respectively. The absence of the inhibitory effect observed with FSc dye in this work is perhaps 
related with the use of cell suspensions with higher cell density, indicating that differences on 
inoculum size may influence their susceptibility profile [119]. 
 
 With the results obtained on the antifungal susceptibility assays it was assured that C. 
albicans suspensions with high cellular concentrations are poorly susceptible to both FSc and 
FSd dyes alone. The non-existent or lower antifungal activity of compounds alone is one required 
principle in their ideal profile as photosensitizer [5, 65]. So, these observations encouraged the 
transition to the APDT assays of C. albicans biofilms using FSc and FSd dyes as photosensitizers.  
3.2. Antifungal Photodynamic Therapy 
Before testing and optimizing the antifungal photodynamic efficacy of FSc and FSd dyes 
against C. albicans biofilms, dyes concentrations were firstly defined. Given that antifungal 
susceptibility assays showed that there is a very poor antifungal activity of dyes on concentrations 
tested in planktonic cells, higher concentrations of dyes (100, 200 and 300 μM) were selected 
for APDT assays, since usually biofilms are more resistant to antifungal drugs than their 
planktonic counterparts [13, 34-36]. 
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 The dark toxicity of these dyes on C. albicans biofilms using the set of concentrations 
mentioned above was firstly determined using a dark incubation period of 3 h with the intent to 
assess their dye alone effect using such incubation conditions. Figure 8 shows the resultant dark 
toxicity of both dyes on C. albicans biofilms.  
  
Figure 8. Logarithm of number of C. albicans ATCC 90028 biofilm cells per cm2 after 3 h of dark 
incubation with FSc (A) and FSd (B) dye at different concentrations in PBS. Error bars represent standard 
deviation. *Statistically different from the control, 0 μM (P <0.05).  
As shown in Figure 8, dyes concentration of 100 and 200 μM showed no inactivation 
effect (P >0.05) of C. albicans biofilms. On the other hand, it was observed a little inactivation (P 
<0.05) of these biofilms when FSc and FSd dyes were used at 300 μM, been the killing effect at 
this concentration 0.62 log and 0.40 log, respectively. Indeed, it is clearly evident that dark 
toxicity of both dyes against C. albicans biofilms was very low at the conditions used.  Given the 
clinical use of APDT ideally requires photosensitizers without dark activity, this set of dark 
incubation conditions could be ideal for APDT of C. albicans biofilms if it was achieved great 
levels of cell inactivation upon irradiation  [5, 65]. So, such dark incubation conditions were then 
used in the first APDT assays of both dyes.  On APDT assays, after dark incubation with dyes, 
biofilms were aseptically illuminated with a xenon arc lamp during 20 and 60 minutes, 
corresponding respectively to light fluences of 12 and 36 J cm-2. Two controls: absence of dye 
only with light and absence of light, only with dye at different concentrations were also performed 
in parallel. The susceptibility of C. albicans biofilms to the photosensitization assays using FSc 
and FSd is shown in Figure 9. 
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Figure 9.  Logarithm of number of C. albicans ATCC 90028 biofilm cells per cm2 after 3 h of dark 
incubation with FSc (A) and FSd (B) dye at different concentrations in PBS followed of exposure to 
various light doses. Error bars represent standard deviation. *Statistically different from the control, 0 μM 
(P <0.05). 
 
 In comparison with the respective control of absence of light only with dyes at different 
concentrations (0 J cm-2), a statically significant (P <0.05) decrease of cell viability (0.63 log) was 
achieved after APDT, using FSc at 300 μM and the illumination fluence of 36 J cm-2 (60 minutes 
of biofilm illumination). The others APDT conditions tested with FSc and all of conditions tested 
with FSd dye showed no photodynamic effectiveness against C. albicans biofilms (P >0.05). In 
addition, exposure to light alone had no effect on C. albicans cells viability.  
 
In order to improve the photodynamic action of both dyes, it was defined a new period of 
contact in the dark of 18 h. This was grounded on the possible influence of dark incubation time 
on dye uptake that, consequently, would have an effect on APDT effectiveness of dyes [88, 120, 
121]. Figure 10 presents the cell viability after 18 h of contact of biofilms with dyes. 
Figure 10. Logarithm of number of C. albicans ATCC 90028 biofilm cells per cm2 after 18 h of dark 
incubation with both FSc and FSd dyes at different concentrations in PBS. Error bars represent standard 
deviation. * Statistically different from the control, 0 μM (P <0.05). 
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Data presented in Figure 10 turns very clear that FSc dye had some dark activity in 
contrast to FSd dye that had no dark activity against C. albicans biofilms (P > 0.05). The significant 
(P< 0.05) cell viability reduction achieved with FSc dye was approximately 1 log and 1.63 log when 
it was used concentrations of 200 and 300 μM, respectively. However, there still was a potential 
to achieve higher levels of cell inactivation by performing APDT of C. albicans biofilms using these 
dark incubation conditions with dyes. So, new APDT assays were performed using such dark 
incubation conditions. The results of these APDT assays are presented on Figure 11.  
  
 
Figure 11. Logarithm of number of C. albicans ATCC 90028 biofilm cells per cm2 after 18 h of dark 
incubation with FSc (A) and FSd (B) dye at different concentrations in PBS followed of exposure to 
various light doses. Error bars represent standard deviation.*Statistically different from the control, 0 μM 
(P <0.05). 
The use of a longer dark incubation period turned FSc highly photodynamic effective 
against C. albicans biofilms. In comparison with the control conditions (0 J cm-2), a significant 
decrease (P <0.05) of 0.95 log and 1.32 log of C. albicans viability was achieved when FSc 
concentration was, respectively, 200 μM and 300 μM, and the light fluence 12 J cm-2 (20 
minutes of illumination). Nevertheless, the most effective conditions for photodynamic action 
were obtained with a light fluence of 36 J cm-2 (60 minutes of illumination), demonstrating that 
the killing effect using FSc occurs in a fluence-dependent manner [92, 98]. A significant decrease 
(P <0.05) on cell viability of 1.47 log, 1.77 log and a complete inactivation were observed when it 
was used FSc at 100, 200, and 300 μM, respectively, combined with a light fluence of 36 J cm-
2. In opposition, FSd dye showed no photodynamic action even when all dyes concentrations 
were combined with the highest light fluence (36 J cm-2). For this reason, it was decide that the 
lower light fluence (12 J cm-2) could be discarded of this assay.  
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The increasing incidence of localized fungal infections combined with the rise of drug-
resistant strains has led to the investigation of new antifungal approaches. Photodynamic therapy 
emerged as a promising approach due to the antimicrobial effectiveness against several 
microorganisms. Accordingly to Kato et al. [97], APDT  treatments may inhibit virulence factors 
and reduce in vivo pathogenicity of C. albicans without causing alterations in daughter cells, 
suggesting that APDT effects are transitory and strengthening that APDT approach could be 
indeed a promising alternative therapy to treat C. albicans infections. In this study it was 
achieved an optimal set of APDT conditions that promises a complete inactivation of C. albicans 
biofilms. With the benzo[a]phenoxazinium chloride termed FSc at 300 μM (119.25 mg l-1) and 
using a dark incubation period of 18 hours followed by illumination with a light fluence of 36 J 
cm-2, it could accomplished a complete eradication of C. albicans biofilms. This successfully 
achieve indicate that FSc-mediated APDT might be a potential new approach to treat C. albicans 
infections.  
The susceptibility of fungal species to photodynamic action of several photosensitizing 
dyes and lights with appropriate wavelengths has been receiving increased attention in the last 
few years. Indeed, a complete eradiation of C. albicans biofilms was previously reported by 
Teichert et al. [101] using a murine model. Nevertheless, the authors described the use a higher 
dye concentration (450 and 500 mg l-1 of MB) and higher light doses (275 J cm-2). The use of 
similar APDT conditions to this study that inactivates C. albicans biofilms was reported by Dovigo 
et al.  [87]. The study was developed using a commercial porphyrin termed Photogem® at 25 
mg l-1 and a blue LED light at 37.5 J cm-2. However, the cell viability reduction achieved was less 
than 1 log. In 2006, Foley et al. [103] had described so far the first benzo[a]phenoxazinium 
analogue that was highly effective in APDT of C. albicans – a  benzo[a]phenoselenazinium dye. 
The authors achieved a 99% of cell killing when planktonic cultures of 107 cells ml-1 were 
incubated during 10 minutes with this dye at 20 μM and then exposed to a light with only a 4 J 
cm-2 of fluence. A comparative study between FSc and the benzo[a]phenoselenazinium dye in the 
APDT of C. albicans biofilms, could be an interesting and enriching contribute for the research in 
this field. 
The previous work performed with FSc dye [117] achieved a 67.1% of cell inactivation 
when C. albicans planktonic cultures of 4 x 107 cells ml-1 were incubated during 60 minutes with 
the FSc dye at 200 μM and illuminated at 12 J cm-2 of fluence. In this study it was necessary a 
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higher dye concentration, a longer incubation time and a higher illumination fluence to achieve a 
significant reduction of cell viability on C. albicans biofilms using FSc as photosensitizing agent. 
These differences on APDT conditions are due to the structural differences between planktonic 
and biofilm grown-cells [33]. At this respect Donnelly et al. [122] reported an interesting study. 
The authors designed a mucoadhesive patch containing 50 or 100 mg cm-2 of TBO with suitable 
properties to be used as controlled delivery system in APDT of oropharyngeal candidosis. As a 
conclusion of their study, they achieved that short time period of mucoadhesive patches with this 
dye could be used to treat recently acquired oropharyngeal candidosis caused by planktonic 
cells, but longer application times of the patch or longer illumination periods may be required to 
treat infections caused by C. albicans biofilms [122]. These observations lend support to the 
notion that higher application times of the photosensitizer or/and longer light illumination periods 
are needed when biofilms are implicated. 
The susceptibility of C. albicans biofilms to APDT by using a benzo[a]phenoxazinium 
chloride, as photosensitizing agent, is an important step in the potential use of this novel 
therapeutic strategy to treat fungal infections. Obviously, the issue of selectivity will be an 
important one, since healthy human tissues can be susceptible to damage of APDT treatments. 
Nevertheless, the potential for topical application of dyes and light application only to affected 
sites in mucocutaneous candidosis makes these infections particularly amenable to APDT [92]. 
Zeina et al. [123, 124] have demonstrated that APDT with MB under conditions that lead to 
effective killing of common skin microorganisms, including C. albicans, cause neither cytotoxicity  
nor DNA damage to keratinocytes in vitro, supporting the belief that selectivity for the 
microorganism may be possible for mucocutaneous candidosis. However, some in vivo data will 
always be important. 
 
3.3. Dye Uptake 
 
According to Foley et al. [103], the APDT effectiveness might depends on photochemical 
efficiencies of dyes, the degree of dye absorption and cell-dye binding, or both. It is interesting to 
note that the crossing of all APDT results using FSc suggests that increasing dye’s concentration 
and the time of dark incubation resulted on a higher photodynamic efficacy of the dye. On the 
other hand, the APDT results using FSd showed that increasing dye’s concentration or the 
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incubation period had no influence on its APDT effectiveness. In fact, the uptake of 
photosensitizers is an important feature for the efficacy of photoinactivation [125]. So, to 
demonstrate if differences on APDT effectiveness were mostly related with dye uptake, even as to 
observe if that effect was influenced in a concentration-dependent manner, it was accessed the 
concentration of dye (on the supernatant) that were retained on biofilm matrix and absorbed by 
C. albicans cells after incubation in the dark (Table 4). 
 
Table 4. Uptake of FSc and FSd by biofilms of C. albicans ATCC 90028 after dark incubation with both 
dyes at 100 and 300 μM in PBS for 3 h or 18 h. The values are means ± Standard deviations 
 
Initial 
concentration of 
dye(μM) 
Concentration of dye on supernatant (μM) 
Dye retained on biofilm matrix Dye absorbed by cells 
3 h 18 h 3 h 18 h 
F
S
c 
100 0,54 ± 0,03 0,89 ± 0,25 1,49 ± 0,43 3,46 ± 0,44 
300 2,22 ± 0,21 8,69 ± 1,03 3,98 ± 0,54 13,52 ± 4,90 
F
S
d 
100 0,48 ±0,31 1,25 ± 0,21 0,13 ± 0,02 0,70 ±0,04 
300 0,61 ± 0,27 1,61 ± 0,04 0,14 ± 0,03 0,64 ±0,19 
* Statistically different from the same situation at 3 h of dark incubation (P <0.05). 
Δ Statistically different from FSd in the same conditions (P <0.05).  
 
The results presented on table 4 confirmed that FSc dye is generally highly absorbed by 
biofilm matrix and C. albicans cells, when compared to FSd dye. Comparing both dyes in the 
same incubation conditions, FSc was more absorbed (P <0.05) by cells when 100 μM of the dyes 
were used during 18 hours in the dark. When higher concentration (300 μM) was used, FSc was 
also significantly more absorbed (P <0.05) by both biofilm matrix and C. albicans cells on all dark 
incubation periods used.  
 
Interestingly, the same results (Table 4) also show that FSc uptake by the biofilm matrix 
and cells occurs in a concentration-dependent manner on both dark incubation periods (P <0.05). 
Combining these remarks with the results presented in figures 10 and 13, it is clear evident the 
photoinactivation of C. albicans biofilms with this dye is significantly influenced by the dye uptake 
phenomenon and also its APDT outcomes were dependent on dye concentration [92, 101]. In 
contrast, besides the FSd uptake seems to be very poor it was not also influenced by increasing 
* 
Δ 
  Δ * 
  Δ
 
Δ   * 
    Δ
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the initial concentration of dye (P >0.05). Indeed, the concentration can be an important feature 
on dye uptake, on its cellular localization and, consequently in the photodynamic inactivation of 
cells [66]. The occurrence of a concentration-dependent photoinactivation of C. albicans was also 
observed previously by others authors. For instance, Bliss et al. [92] and Teichert et al. [101] 
reported that C. albicans photoinactivation using, respectively, photophrin and MB as a 
photosensitizing dye occurs also in a concentration-dependent manner.  
The incubation time is a variable that also may affects the uptake of the dye and its 
cellular localization and, consequently, affects inactivation of the yeasts [66]. The results of this 
study showed the effectiveness of APDT on C. albicans biofilms using FSc is dependent on 
incubation time, been its best APDT outcomes achieved with the maximum period of dark 
incubation tested (18 hours). Comparing the results achieved on both dark incubations periods 
used, it was observed that there was a significant increase of dye absorbed by cells by increasing 
dark incubation period from 3 to 18 hours, using FSc at 100 μM. Likewise, increasing dark 
incubation periods from 3 to 18 hours using an initial FSc concentration of 300 μM resulted on a 
significant increase (P <0.05) not only of dye taken up by C. albicans cells but also dye retained 
on the biofilm matrix. In contrast, the FSd uptake was not also influenced by the incubation time 
(P >0.05). Accordingly, Jackson et al. [120], as well as Wilson and Mia [121] described that APDT 
of planktonic cultures of C. albicans using TBO was dependent on incubation time used. 
Moreover, Dovigo et al. [88] reported also that inactivating C. albicans biofilms with curcumin-
mediated APDT is markedly increased with the increasing of incubation time. 
In short, crossing APDT and dye uptake results emphasizes that under conditions where 
FSc was effectively taken up by both biofilm matrix and C. albicans cells, the illuminated biofilms 
are significantly inactivated, being the concentration of dye and the incubation time two important 
variables for the efficient dye uptake occurs. However, the same remarks were not observed 
when FSd dye is used. Therefore, the differences on APDT efficacy of FSc and FSd are perhaps 
mostly related with dye uptake, and so the optimal APDT outcome achieved with FSc dye is 
probably due to higher levels of dye uptake by the biofilm matrix and cells at the incubations 
conditions used. As high is the amount of dye retained on the biofilm matrix or taken up by cells, 
the higher will be probability to form a great amount of singlet oxygen and ROS during the light 
excitation, resulting on  a bigger oxidative stress that leads to a better killing effect [5, 64, 65]. It 
is also important to denote that although the amount of dye bonded and absorbed by cells had a 
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crucial role to inactivate the biofilm population, dye retained on the biofilm matrix was also a 
crucial feature for the photodynamic inactivation of biofilms. The resulting singlet oxygen 
produced at this sites during illumination could exerts effect on matrix polysaccharides, leading to 
the biofilm destruction, or could damage the outer structures of the cell, directly allowing more 
dye to enter into the cell and cause cell death, accelerating the APDT effect [3, 9]. 
Fluorescence microscopy analysis of planktonic cells and biofilm resuspended cells after 
incubation in the dark during 3 and 18 h with both dyes at 300 μM in PBS was also performed 
with the intent to obtain a visual result of some data presented on Table 4. Figures 12 and 13 
show the resulting micrographs for planktonic cells and biofilms resuspended cells, respectively.  
  
 
  
Figure 12.  Fluorescence microscopy micrographs obtained for C. albicans ATCC 90028 planktonic cells 
after 3 h of incubation (A1-A3) and 18 h of incubation (B1-B3) with PBS only, as well as with FSc and 
FSd dye at 300 μM in PBS. 
A1 - Negative control B1 - Negative control 
A2 - FSc B2 - FSc 
A3 - FSd B3 - FSd 
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 Figure 13. Fluorescence microscopy micrographs obtained for C. albicans ATCC 90028 biofilm 
resuspended cells after 3 h of dark incubation (A1-A3) and 18 h of dark incubation (B1-B3) with PBS 
only, as well as with FSc and FSd dye at 300 μM in PBS.  
 
It was possible to observe that on both situations, particularly on biofilm resuspended 
cells, the dark incubation with FSc resulted on higher levels of cell fluorescence, suggesting the 
levels of uptake of FSc was much higher than FSd dye. This qualitative analysis is in accordance 
with the results presented on Table 4. However, it is important to highlight that FSc and FSd have 
different absolute fluorescence quantum yields (Table 3), which are likely to result in some 
differences of fluorescence intensity observed.  
Interestingly, it is also well clear on both figures that increasing the dark incubation 
period do not resulted on higher levels of fluorescence, as it was expected. Instead, it seems to 
influence the formation of little points of fluorescence, suggesting dye concentration at some cell 
A1 - Negative control B1 - Negative control 
A2 - FSc  B2 -FSc 
A3 - FSd B3 - FSd 
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clusters. However, further investigations are required to confirm this observation.  In fact, as it 
was mentioned previously, dyes can cross over the plasma membrane, especially after prolonged 
incubation periods, and take different subcellular localizations, such as mitochondria, nucleus, 
vacuoles or Golgi apparatus, as well as in endoplasmic reticulum [66]. Upon illumination, the 
ROS produced at these sites can cause damage to these constituents, inactivating some proteins 
and enzymes, oxidizing nucleic acids and peroxidizing lipids of the surface membrane, leading to 
the loss of cell viability [9, 72].  
The higher cell fluorescence when FSd was incubated with planktonic cells, instead 
biofilms, was also remarkable. Figure 16 shows when there is no presence of biofilm matrix, FSd 
dye can do a larger binding to C. albicans cells, indicating that much of the small amount of dye 
absorbed by biofilms stays perhaps retained in the biofilm matrix.  
Treatment efficacy could depend on the specificity of the compound to the target. 
Typically, specificity to targets could be increased by using macromolecular conjugates [118]. In 
this study, it was explored the possibility to enhance specificity of benzo[a]phenoxazinium salts to 
C. albicans cells, through small functional groups modifications. The presence of the distinct side 
chains on FSc and FSd dyes are presumably the responsible for distinct levels of dye uptake by 
C. albicans and, consequently, for the differences on its APDT outcomes. Besides side chain 
modifications may have a little effect on photophysical properties of photosensitizers [118], the 
presence of a longer side chain on FSd dye are presumably make more difficult its entry and 
diffusion throughout the biofilm matrix, impairing the cell-dye binding and dye uptake. Plus, data 
presented on Appendix A showed that the absorption peak of FSd dye seems to be shifted 40-70 
nm to the left, in relation to the initial absorption peak (616 nm), after incubation with C. albicans 
biofilms. This shift is probably related with the formation of aggregates that absorb light at fewer 
wavelengths than the wavelength of maximum absorption of the dye [115, 126, 127].  The 
formation of dye aggregates is presumably enhancing the barrier effect of the biofilm matrix, 
making difficult its penetration in this structure and its arrival to cells, leading to a non-existent 
APDT action. Nevertheless, the hypothesis that the presence of a longer side chain on FSd 
molecules grants also them a higher affinity to the biofilm matrix components is not also out of 
the hypothesis.  
4. CHAPTER IV
CONCLUSIONS AND
FUTURE PERSPECTIVES 
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The interest on APDT approach to treat fungal infections has been receiving an increased 
attention in our society in the last few years. The increasing of fungal infections due to the 
augmented use of indwelling devices and the growth of imunocompromised patients, as well as 
the emergence of drug resistant strains are the principal reasons that triggered the interest in a 
more effective and localized therapeutic approach to treat these microbiological diseases. Despite 
the numerous APDT investigations and the rising development of new photosensitizers that are 
photodynamic effective against a several range of pathogens, there is still a need to investigate 
and explore the potential of APDT approach to treat fungal infections, especially when originated 
by biofilms. With the intent to fill this gap of knowledge, this project aimed to evaluate and 
optimize the photodynamic antifungal activity of two new benzo[a]phenoxazinium chlorides (FSc 
and FSd) against C. albicans biofilms. 
Regarding to the antifungal susceptibility testing of dyes, FSd dye showed to have a very 
small dark activity against C. albicans planktonic cells when used at 50 and 100 μM, while FSc 
dye showed no dark activity on all conditions tested. In relation to the antifungal photodynamic 
action, only FSc dye showed a photodynamic killing effect against C. albicans biofilms, been 
achieved a complete cell inactivation using FSc dye at 300 μM in contact with C. albicans 
biofilms during 18 h, followed by light exposition (600 ± 2 nm) with a fluence of 36 J cm-2. The 
interest on benzo[a]phenoxazinium chlorides as photosensitizers agents to treat C. albicans 
infections by APDT grows with these results, because FSc dye showed to have an optimal 
photosensitizing activity in the APDT of C. albicans biofilms. However, it was also important to 
understand the uneven APDT outcomes achieved, so another important part of this study 
addressed the investigation of a potential correlation between dye uptake and APDT effectiveness 
of dyes by spectrofluorimetric analysis and fluorescence microscopy. 
As a conclusion of this second part of the study, it was possible to observe that the 
differences in efficacy  of FSc dye over FSd  and  the increasing of  its effectiveness  with  
incubation time  are  due to a higher dye  uptake  by  the  biofilm  matrix and  cells. 
In conclusion, this study permitted to increase and to expand the knowledge about the 
APDT action of benzo[a]phenoxazinium chlorides on C. albicans biofilms towards new 
perspectives, since their APDT action on biofilms has remained unknown. 
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As future work, it would be interesting to determine the exactly intracellular localization of 
the FSc dye after the dark incubation period, in order to understand its mechanism of action. The 
execution of confocal microscopy analysis of biofilms incubated for long times with FSc dye may 
bring some important visual information about the intracellular localization of dye taken up by 
cells.  Additionally, to determine the molecular mechanisms that lead to cell necrosis or 
apoptosis would be also an advance towards the knowledge about APDT action of these 
benzo[a]phenoxazinium chlorides. 
The use of a target delivery of photosensitizers to cells is increasing and has been shown 
to be very promising in the APDT field. Thus, to explore the potential integration of FSc dye into 
nanoparticles that may be also combined with specific antibodies for the target could be an 
interesting approach that should be investigated. Likewise, the synergic effects of FSc-mediated 
APDT with compounds that create pores within the fungal membrane and increase the cellular 
uptake, such as amphotericin B and nystatin, may be an interesting approach that may also be 
explored on further investigations in this field. Nonetheless, additional information about the 
possible development of cellular resistance to FSc-mediated APDT treatments as well as to the 
combination of APDT with the strategies mentioned above should be also considered on 
subsequent investigations. 
Given the high clinical relevance of fungal biofilms and the potential clinical application of 
APDT to treat candidosis, there is a substantial need to provide a deep understanding about the 
implications of these treatments in humans. Thus, it would be also important to evaluate the 
potential cytotoxic effects on mammalian cells arising from the incubation with the 
benzo[a]phenoxazinium chloride FSc during 18 h, as well as from the posterior combination with 
the light.  
In real life, almost all localized infections are caused by polymicrobial biofilms, especially 
when a HIV-infected patient is involved. Therefore, to evaluate the effects of FSc-mediated APDT 
on the viability of mixed biofilms formed by pathogenic microorganisms, such as C. albicans, 
Staphylococcus aureus and Staphylococcus mutans would be very interesting. Plus, in vivo 
studies will be also important for the development of this new potential APDT strategy. The 
development of these two approaches could help to mimic the real problem of localized 
infections and to understand to what extent this new therapeutic strategy could treat efficiently 
this type of disease.  
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These are some of many perspectives of investigation in the field of APDT. The interest 
and the necessity to turn this approach in a real solution to treat superficial infections are 
growing and these are the main driving forces under the research in this area. 
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 Appendix A - Absorption Spectra of Biofilms 
As mentioned on section 2.7.3. selected absorption spectrum of illuminated biofilms are 
presented below (Figures A1 to A7). The absorption spectra were determined for each condition 
performed on photodynamic inactivation assays previously and after light exposure.  
Figure A 1. Absorption spectra of biofilms of Candida albicans ATCC 90028 before and after exposure to 
a light fluence of 12 J cm-2 following  3 h of incubation with FSc dye at 100 μM (A), 200 μM (B) and 300
μM (C) in PBS. 
Figure A 2. Absorption spectra of biofilms of Candida albicans ATCC 90028 before and after exposure to 
a light fluence of 12 J cm-2 following  3 h of incubation with FSd dye at a 100 μM (A), 200 μM (B) and
300 μM (C) in PBS. 
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Figure A 3. Absorption spectra of biofilms of Candida albicans ATCC 90028 before and after exposure to 
a light fluence of 36 J cm-2 following  3 h of incubation with FSc dye at 100 μM (A), 200 μM (B) and 300
μM (C) in PBS. 
Figure A 4.  Absorption spectra of biofilms of Candida albicans ATCC 90028 before and after exposure 
to a light fluence of 36 J cm-2 following  3 h of incubation with FSd dye at 100 μM (A), 200 μM (B) and
300 μM (C) in PBS. 
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Figure A 5. Absorption spectra of biofilms of Candida albicans ATCC 90028 before and after exposure to 
a light fluence of 12 J cm-2 following  18 h of incubation with FSc dye at 100 μM (A), 200 μM (B) and
300 μM (C) in PBS. 
Figure A 6. Absorption spectra of biofilms of Candida albicans ATCC 90028 before and after exposure to 
a light fluence of 36 J cm-2 following  18 h of incubation with FSc dye at 100 μM (A), 200 μM (B) and
300 μM (C) in PBS. 
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Figure A 7. Absorption spectra of biofilms of Candida albicans ATCC 90028 before and after exposure to 
a light fluence of 36 J cm-2 following  18 h of incubation with FSd dye at 100 μM (A), 200 μM (B) and
300 μM (C) in PBS. 
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Appendix B – Calibration Curves 
As described by Guilbault, G. [128], calibration curves of fluorescence intensity versus 
concentration of dye were determined only for dyes concentrations with absorbance below 0.1 to 
avoid the phenomenon of concentration quenching of fluorescence, in which high concentrations 
of dye may result on low fluorescence intensity response. Therefore, calibration curves of 
absorbance versus concentration of dye in PBS were firstly determined, at the respective 
wavelength of maximum absorption of each dye.  Figures B1 and B2 show the calibration curves 
of absorbance for FSc and FSd dye, respectively.  Figures B3 and B4 show the respective 
calibration curves of fluorescence intensity for FSc and FSd that were posteriorly determined with 
excitation wavelength set to 590 nm and the emission wavelength set to 645 nm. 
Figure B 1. Calibration curve of absorbance versus FSc dye concentration.  
Figure B 2. Calibration curve of absorbance versus FSd dye concentration.  
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Figure B 3. Calibration curve of fluorescence intensity versus FSc dye concentration. 
Figure B 4. Calibration curve of fluorescence intensity versus FSd dye concentration. 
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